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Abstract 
 
Low-density lipoprotein-derived cholesterol and its intracellularly generated oxidated 
derivatives mediate control mechanisms that protect the cell from overaccumulation 
of cholesterol. The low-density lipoprotein receptor (LDLR) is the key component in 
the feed-back regulated maintenance of cholesterol homeostasis in the body. 
Members of the LDLR gene family are not only involved in lipoprotein transport, but 
also in diverse signal transduction pathways. Common features of these receptors 
are structurally and functionally defined modules, namely the ligand binding type A 
repeats, the epidermal growth factor (EGF) repeats, the so-called YWTD repeats, the 
O-linked sugar domain, the transmembrane domain, and a short cytoplasmic tail 
containing a consensus motif for internalization. 
Endocytic members of the LDLR gene family employ adaptor proteins for efficient 
endocytosis. It is known that the soluble protein ARH interacts with the cytoplasmic 
tails of certain low-density lipoprotein receptor family members in humans. Numb, 
another adaptor protein originally shown to be involved in endocytosis in Drosophila, 
is closely related to ARH. 
In this thesis, the chicken was used as model system, as it is a well characterized 
organism in terms of biology and molecular genetics for studies on receptor-mediated 
lipoprotein metabolism. For instance, the first avian LDLR has been identified in the 
chicken. Apolipoprotein E (apoE) is an important ligand for the mammalian LDLR, but 
is not expressed in birds and does not bind to the avian receptor. In order to shed 
further light on the requirements for recognition of apoE, one goal of the thesis was to 
mutate the chicken LDLR’s ligand binding domain such that the receptor gains the 
ability to bind apoE. Accordingly, mutations were introduced, and the ligand binding 
behaviour of the altered LDLR was tested. The mutated ligand binding domains 
generated, retained binding of the common chaperone receptor-associated protein. 
However, in ligand blot studies, the mutated domains of the chicken LDLR failed to 
bind any of the human apoE isoforms. Thus, ligand binding properties are possibly 
determined by structural features other than, or in addition to, those investigated. 
Recently, Numb was found in avian neuroepithelial cells. Through database search I 
localized the avian gene for Numb on chromosome 5, and I was able to identify 4 
different isoforms containing various inserts and combinations thereof. I performed 
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interaction studies of the human and chicken LDLR’s cytoplasmic tails with different 
Numb isoforms and could demonstrate that isoform 3 binds to both cytoplasmic tails 
despite lacking the phosphotyrosine-binding domain insert shown to be important for 
ARH’s binding to the NPxY motif in the tails. These results indicate that, at least in 
the chicken, the phosphotyrosine-binding domain insert may not be crucial to the 
recognition of receptor-internalization motifs by the adaptor protein Numb. 
Amnionless is a co-receptor for Cubilin, which is a protein, thought to complex only 
with LRP2, another member of the LDLR family. LRP2 contains three internalization 
motifs and binds ARH. Amnionless is not a bona-fide lipoprotein receptor, but 
contains two internalization signals for receptor-mediated endocytosis, which likely 
mediate the demonstrated binding of chicken ARH to the intracellular domain of 
avian Amnionless. I also investigated whether chicken Numb is also able to interact 
with this domain; however, the results indicate that such interaction does not take 
place, possibly related to the different physiology of avian species. 
 
Zusammenfassung 
 
- 11 - 
Zusammenfassung 
 
LDL-Cholesterin und seine intrazellulär erzeugten oxidierten Derivate vermitteln eine 
Reihe von „Feedback“ Kontrollmechanismen, die die Zelle vor einer Überladung mit  
Cholesterin schützen. Der LDL Rezeptor (LDLR) ist die Hauptkomponente der 
regulierten Aufrechterhaltung der Cholesterinhomöostase im Körper. Mitglieder der 
LDLR Genfamilie sind nicht nur in den Lipoproteintransport involviert, sondern auch 
in verschiedene Signaltransduktionswege. Gemeinsame Merkmale dieser 
Rezeptoren sind strukturell und funktionell definierte Bausteine wie die Typ A 
Ligandenbindungsdomänen, die epidermalen Wachstumsfaktor-Domänen, die 
sogenannten YWTD Domänen, die O-glykosilierte Domäne, die 
Membranankerdomäne und eine kurze zytoplasmatische Domäne. 
Endozytierende Mitglieder der LDLR Genfamilie setzen Adaptorproteine für effiziente 
Endozytose ein. Es ist bekannt, dass das lösliche Protein ARH mit dem 
zytoplasmatischen Teil von gewissen LDLR Familienmitgliedern im Menschen 
interagiert. Numb, ein weiteres Adaptorprotein welches ursprünglich in Drosophila 
entdeckt wurde, ist ebenfalls an Endozytose beteiligt und mit ARH nahe verwandt. 
In meiner Arbeit wurde das Huhn als Modellorganismus benutzt, da es für Studien an 
rezeptor-vermitteltem Lipoproteinstoffwechsel und in Bezug auf Biologie und 
Molekulargenetik gut charakterisiert ist; so ist z.B. der erste Vogel-LDLR im Huhn 
identifiziert worden. In Säugetieren ist Apolipoprotein E (ApoE) ein wichtiger 
Bindungspartner für den LDLR. In Vögeln wird dieses Apolipoprotein allerdings nicht 
exprimiert und das humane ApoE bindet auch nicht an den Hühner-LDLR. Um 
tieferen Einblick in die Mechanismen der Ligandenbindung zu gewinnen, war es ein 
Ziel dieser Arbeit die LDLR Ligandenbindungsdomäne im Huhn so zu mutieren, dass 
der Rezeptor die Fähigkeit erlangt das ApoE zu binden. Dementsprechend wurden 
Mutationen eingebracht und das Bindungsverhalten des veränderten LDLRs 
getestet. Alle mutierten Ligandenbindungsdomänen waren in der Lage das bekannte 
Chaperon rezeptor-assoziiertes Protein zu binden, allerdings konnte die Bindung an 
keine der humanen ApoE-Isoformen, zumindest in Liganden Blot Studien, gezeigt 
werden. Die Resultate deuten darauf hin, dass die ApoE-Bindung wahrscheinlich 
durch andere, oder zusätzliche zu den untersuchten, Strukturelemente bestimmt 
wird. 
Zusammenfassung 
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Vor kurzem wurde Numb in neuroepithelialen Zellen im Huhn gefunden. Durch 
Datenbanksuche konnte ich das Numb-Gen auf Chromosom 5 lokalisieren und 4 
verschiedene Isoformen, die 2 Arten von Inserts und Kombinationen davon 
enthalten, identifizieren. Durch Interaktionsstudien der zytoplasmatischen Teile des 
menschlichen und des Hühner-LDLR mit verschiedenen Numb Isoformen konnte ich 
zeigen, dass die Numb Isoform 3 in der Lage ist, beide  zytoplasmatischen Domänen 
zu binden, selbst wenn das Insert in der Phosphotyrosin-Bindungsdomäne fehlt. Von 
diesem Insert weiß man, dass es für die Bindung von ARH an die NPxY Sequenz im 
zytoplasmatischen Teil des Rezeptors wichtig ist. Diese Ergebnisse weisen 
daraufhin, dass das Insert in der Phosphotyrosin-Bindungsdomäne von Numb, 
zumindest im Huhn, für die Erkennung von Rezeptor-Internalisierungssignalen durch 
das Adaptorprotein Numb nicht ausschlaggebend ist. 
Amnionless wurde als Co-Rezeptor von Cubilin identifiziert. Cubilin war bisher nur als 
Interaktionspartner von LRP2, einem Protein aus der LDLR-Familie, bekannt. LRP2 
besitzt drei Internalisierungssignale im zytoplasmatischen Teil und kann ARH binden. 
Obwohl Amnionless nicht zur LDLR-Familie gehört, weist es zwei 
Internalisierungssignale für Endozytose auf, und es wurde gezeigt, dass die 
intrazelluläre Domäne von Hühner-Amnionless an Hühner-ARH bindet. 
Ich habe untersucht, ob Hühner-Numb auch mit der zytoplasmatischen Domäne von 
Hühner-Amnionless interagieren kann. Die Daten weisen daraufhin, dass eine solche 
Interaktion nicht stattfindet, was mit der unterschiedlichen Physiologie des Huhnes im 
Zusammenhang stehen könnte. 
 
Introduction 
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Introduction 
 
Amnionless  
 
Amnionless was initially identified as a yolk sac protein in the mouse, essential for 
amnion and primitive streak formation (Kalantry, Manning et al. 2001). 
The amnionless gene, amn, located on mouse chromosome 12, encodes a type I 
transmembrane protein of approximately 50kDa (Kalantry, Manning et al. 2001). The 
Amnionless protein (Fig. 1) has one transmembrane domain (TM) separating a 
larger, N-terminal extracellular region and a smaller, C-terminal cytoplasmic region 
(Tanner, Aminoff et al. 2003). The extracellular region contains a cysteine-rich 
domain (CRD) consisting of 70 amino acids, and is the most conserved region of 
vertebrate Amnionless proteins.  
 
 
 
 
 
 
 
 
The CRD is also present in a small group of proteins known to function as bone 
morphogenetic protein (BMP) inhibitors, for example the Xenopus laevis protein 
Chordin (Kalantry, Manning et al. 2001). Two motifs for receptor internalization 
(NPxY), reminiscent of those in low-density lipoprotein receptor family members, are 
located in the C-terminal part of the protein. The Amnionless protein comprises two 
potential glycosylation sites on amino acid positions 27 and 355 (Uniprot/Swiss-Prot). 
Amnionless is exclusively expressed on the apical surface of the visceral endoderm 
(VE) facing the maternal environment during gastrulation (Kalantry, Manning et al. 
2001). It is also expressed in kidney proximal tubules and intestinal epithelium, 
which, like the VE, are polarized epithelia specialized for resorption and secretion 
(Strope, Rivi et al. 2004). Homozygous inactivation of amn causes embryonic 
lethality in mice, whereas mice carrying the amn mutation, a transgene-induced 
Figure 1. Scheme of Amnionless structure.  
A detailed description is given in the text. CRD, cysteine-rich domain; TM, 
transmembrane domain; NPxY, internalization sequence; 
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insertional mutation (Wang, Bornslaeger et al. 1996), are unable to develop an 
amnion (Tanner, Aminoff et al. 2003). In humans the amnionless gene lies on 
chromosome 14q32 (Kalantry, Manning et al. 2001), and there is no apparent need 
for Amnionless until after birth. 
 
 
Amnionless in human disease 
 
Imerslund-Gräsbeck syndrome (IGS or megaloblastic anemia 1) is an autosomal 
recessive disorder. It is characterized by selective cobalamin (vitamin B12) 
malabsorption, despite normal function and production of intrinsic factor (IF) 
(Grasbeck, Gordin et al. 1960; Imerslund 1960), with proteinuria. Additionally, the 
disease includes failure to thrive and grow, infections and neurological damage 
(Grasbeck 2006). 
Cobalamin is a coenzyme for methylmalonyl-CoA mutase and methionine synthase, 
enzymes of intermediate metabolism. Gastrointestinal malabsorption of this nutrient 
leads to megaloblastic anemia, neutropenia, degeneration of spinal cord nerve tracts, 
and dementia (Rosenblatt and Fenton 1999). In children, cobalamin deficiency may 
also lead to growth retardation and loss of developmental progress (He, Madsen et 
al. 2005). 
IF is a glycoprotein, which binds to cobalamin and ensures its absorption from the 
intestine. The IF-cobalamin complex is recognized by Cubilin, which participates in 
the endocytosis of this complex (Moestrup and Verroust 2001; Christensen and Birn 
2002). Data from an earlier study (Aminoff, Carter et al. 1999) provide evidence that 
mutations in Cubilin lead to IGS. 
Recently, the group around Tanner SM (Tanner, Aminoff et al. 2003) showed that 
mutations in the amnionless gene also cause IGS. Canine IGS displays highly 
significant linkage to the same locus (He, Fyfe et al. 2003). Canine IGS was 
observed originally in purebred giant schnauzers and is a naturally occurring animal 
model of the human disorder. 
 
 
 
 
Introduction 
- 15 - 
 
The interaction of Amnionless and Cubilin 
 
Cubilin, also known as intrinsic factor-cobalamin (IF-B12) receptor, is a multiligand 
receptor of about 460kDa. It is expressed in endocytic compartments of absorptive 
epithelia and at the apical plasma membrane, especially the kidney proximal tubule, 
the small intestine, and the visceral yolk sac (Coudroy, Gburek et al. 2005). Thus, its 
tissue distribution is very similar to that of Amnionless. 
Cubilin binds and mediates the clearance of various specific nutrient-carrying 
proteins, such as IF-B12, vitamin-D-binding protein, albumin, transferrin, 
haemoglobin, apolipoprotein A-I, high-density lipoprotein, and Ig light chains 
(Christensen and Birn 2002). Cubilin (Fig. 2) contains no transmembrane domain and 
is composed of an amino-terminal stretch of 106 amino acids followed by eight EGF-
type (epidermal growth factor) repeats, and 27 CUB domains (in all species). 
 
 
 
 
 
 
 
 
 
 
 
 
 
It was shown that Amnionless and Cubilin colocalize early in the biosynthetic 
pathway that is essential for apical membrane localization. Amnionless associates 
with the EGF region of Cubilin to assist each other towards exiting the endoplasmic 
reticulum (Fyfe, Madsen et al. 2004; Coudroy, Gburek et al. 2005). Cubilin is highly 
glycosylated, which could be the major determinant for apical sorting. 
The present data suggest a model in which Amnionless and Cubilin form a functional 
complex (Fig. 3), also designated as cubam complex, which is essential for intestinal 
Figure 2. Schematic drawing of Cubilin.  
For detailed description refer to the text.  
CUB, 27 CUB domains; EGF, 8 EGF-type repeats; 
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cobalamin uptake, renal protein reabsorption and early rodent embryogenesis 
(Grasbeck 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this complex, Cubilin provides the ligand binding regions, whereas Amnionless is 
responsible for membrane anchorage, biosynthetic processing, and trafficking to the 
plasma membrane. Amnionless also provides two putative sequence motifs for 
endocytosis and receptor recycling. 
Interestingly, Cubilin is coexpressed and colocalizes with LRP2 (formerly known as 
megalin) (Fig. 4), a type I transmembrane protein of around 600kDa. Since Cubilin 
has no transmembrane domain, LRP2 seems to mediate the co-internalization and 
possibly the recycling of Cubilin (Moestrup, Kozyraki et al. 1998). But whether the 
two proteins act mechanistically together is unknown. Recently published data show 
that the cubam complex alone is sufficient to internalize IF-B12 (Coudroy, Gburek et 
al. 2005), but it could not be excluded that LRP2 may accelerate the endocytic 
activity of this complex. 
 
 
 
 
 
 
Figure 3. A model of Amnionless and Cubilin assembly in the biosynthetic pathway 
and recycling in the endocytic apparatus of polarized epithelial cells. 
A detailed description is provided in the text. AMN, Amnionless; ER, endoplasmic reticulum 
(Fyfe, Madsen et al. 2004); 
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Figure 4. Model of Amnionless/Cubilin and Cubilin/LRP2 interactions. 
Amnionless and LRP2 bind Cubilin. LRP2 might assist trafficking of Cubilin. 
Amnionless and LRP2 are involved in the endocytosis of Cubilin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The role of cubam and LPR2 during embryonic 
development and nutrition 
 
The Amnionless-Cubilin-LRP2 complex (Fig. 4) seems to be essential for normal 
embryonic development. Altered function of these three proteins during gestation, 
either by using specific antibodies or by knocking out the genes, leads to congenital 
defects and/or embryo-lethality. In LRP2 -/- mice, defective anterior central nervous 
system development was observed. In mice, Cubilin inactivation leads to 
developmental retardation, mesodermal defects, and embryonic lethality around 
midgestation. The absence of Amnionless leads to embryonic lethality at around 
embryonic day 7.5 (E 7.5), triggered by impaired primitive streak assembly (Kozyraki 
and Gofflot 2007). 
The nutrition of the embryo depends on maternal-fetal transport of nutrients through 
the yolk sac VE. The VE has a very high endocytic capacity and expresses 
Amnionless, Cubilin, and LRP2. LRP2 mediates the uptake of cholesterol and does 
not appear to be essential for early embryogenesis. 
Introduction 
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Amnionless and Cubilin seem to be required for endocytosis and/or transcytosis of 
high-density lipoproteins and possibly other factors necessary for proper growth of 
the embryo (Strope, Rivi et al. 2004; Smith, Mussell et al. 2006). 
The knock-out of amn and application of antibodies against Cubilin leads to severe 
defects in mice, but do not have such effects on embryonic development in humans 
and dogs (Aminoff, Carter et al. 1999; Tanner, Aminoff et al. 2003; He, Madsen et al. 
2005). Null-mutations in humans and in the canine model result in the Imerslund-
Gräsbeck syndrome due to malabsorption of IF-B12 complex. These findings 
suggest species-specific differences in visceral endoderm and yolk sac functions. 
The murine visceral yolk sac completely surrounds the developing fetus and serves 
as a maternal-fetal interface required for the exchange of nutrients, oxygen, and 
waste products. In contrast, the human yolk sac becomes a vestigial appendage, and 
trophoblast derivatives act as the major maternal-fetal interface (Strope, Rivi et al. 
2004). These differences possibly explain why cubam is not essential in human 
development. 
 
 
The LDL receptor gene family 
 
The low-density lipoprotein (LDL) receptor (LDLR) gene family comprises a large 
number of structurally closely related members. These proteins are engaged in 
various functions ranging from receptor-mediated endocytosis of a broad variety of 
ligands, especially lipoproteins, to signal transduction pathways as recent studies 
indicate (Li, Cam et al. 2001; Schneider and Nimpf 2003). The first characterized and 
most prominent member of the LDLR gene family is the LDLR (Brown and Goldstein 
1974; Goldstein and Brown 1974). It is the most important component in the tightly 
controlled maintenance of cholesterol homeostasis in the body (Brown and Goldstein 
1986). 
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Figure 5. Schematic model of the LDL receptor. 
A detailed description is given in the text. 
The LDL receptor 
 
The schematic structure of the LDLR is depicted in Fig. 5. Common features of the 
members of the LDLR gene family are structurally and functionally defined modules, 
which are frequently specified by distinct exons in the corresponding genes. 
 
 
 
 
 
 
 
 
 
These domains are head-to-tail-arranged and described as follows: 
 
i. Ligand binding domain: This domain mediates the interaction between 
the receptor and lipoproteins containing apolipoproteinB-100 (apoB100) 
and/or apolipoproteinE (apoE) (Esser, Limbird et al. 1988). The domain, 
located at the amino terminus, consists of seven LDLR type A (LA1-7) 
repeats of approximately 40 residues each. Every repeat has six cysteines, 
which presumably mediate the folding of the domain in a compact structure 
with clusters of negatively charged residues on its surface (with the 
signature tripeptide SDE, Ser-Asp-Glu). These negatively charged clusters 
are thought to mediate binding of lipoproteins through the positively 
charged residues on apoB100 and apoE (Nimpf and Schneider 2000; 
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Schneider and Nimpf 2003). The linkers between the individual repeats are 
thought to provide flexibility to the ligand binding domain in order to allow 
the binding of lipoprotein ligands of different sizes. 
ii. EGF (epidermal growth factor) precursor homology domain: The 
EGFP homology domain is located next to the ligand binding domain. Its 
remarkable characteristic is the sequence similarity to parts of the EGF 
precursor, i.e. three regions termed “growth factor repeats” (A, B, and C in 
Fig. 5: also called type-B repeats). Whereas repeats A and B are located 
aminoterminally, repeat C is located at the carboxyterminus. The residual 
part consists of 6 modules of about 40 residues with a consensus 
tetrapeptide YWTD (Tyr-Trp-Thr-Asp) forming the so-called six-bladed β-
propeller. The β-propeller together with the 3 type-B repeats forms the 
EGF precursor homology domain (Jeon, Meng et al. 2001) of 
approximately 400 residues. The acidic conditions in the endosome lead to 
lipoprotein release from the LDLR ligand binding domain. This triggers a 
conformational change in the receptor, which in turn leads to a closing of 
the structure between the β-propeller and the binding repeats LA4 and LA5 
(Beglova, Jeon et al. 2004; Beglova and Blacklow 2005). 
iii. O-linked sugar domain: The O-linked sugar domain, located just outside 
the plasma membrane, is 58 amino acids long and enriched in serine and 
threonine residues. Most of the 18 hydroxylated amino acid side chains are 
glycosylated. The O-linked oligosaccharides undergo posttranslational 
elongation in the course of receptor maturation. Although the structure of 
this region is very well known, its function remains unclear (Davis, 
Elhammer et al. 1986). 
iv. Membrane anchoring domain: This domain consists of about 20 
hydrophobic amino acids and lies carboxyterminally to the O-linked 
carbohydrate cluster. The sequence of this domain is the least conserved 
of all receptor domains in seven mammalian species. This finding speaks 
against a specific function other than anchoring. Deletion of this domain, in 
naturally occurring mutations or by site-directed-mutagenesis, leads to 
secretion of truncated receptors from the cells. 
v. Cytoplasmic tail: The cytoplasmic tail constitutes a short stretch of 50 
amino acid residues, which are involved in the targeting of the LDLR to 
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clathrin-coated pits. Site-specific mutagenesis and naturally occurring 
mutations have identified an “internalization signal” NPxY (Asn-Pro-Xxx-
Tyr, where x denotes any amino acid). Recently, the cytoplasmic domains 
of the LDLR and its relatives have come into focus due to their involvement 
in transduction of extracellular signaling processes (Willnow, Nykjaer et al. 
1999). 
 
Functions of the LDLR: The LDLR pathway 
 
In the early 1970’s M.S. Brown and J.L. Goldstein started their work to investigate 
and hence to understand the human genetic disease, familial hypercholesterolemia 
(FH). In patients with this disease, the concentration of blood cholesterol is elevated 
many times above normal, and this leads to premature coronary heart diseases. 
These studies resulted in the discovery of the LDLR and to the elucidation of the 
mechanism by which this receptor mediates feedback control of cholesterol 
synthesis. 
FH is caused by inherited defects in the gene encoding the LDLR. These defects 
disrupt the normal control of cholesterol metabolism. 
Normal LDLR function plays a critical role in reducing the risk of atherosclerosis by 
binding to and internalizing lipoproteins that contain apoB100 or apoE. 
In humans, apoB100 is synthesized by the liver and associates with LDL and VLDL. 
ApoE is expressed in liver, brain, kidney, and spleen and associates with VLDL, β-
VLDL, chylomicrons, and less frequently with HDL. Both apolipoproteins, apoB100 
and apoE, function as ligands and interact with the LDLR ligand binding domain. 
The LDLR (Fig. 6) is synthesized by ribosomes and folded, with the help of the 
common chaperone receptor-associated protein (RAP), which is a specialized 
molecular chaperone for the members of the LDLR family, in the endoplasmic 
reticulum (ER). Upon transport to the Golgi network, the LDLR undergoes extensive 
O-linked glycosylation and is transported to the cell surface. At the plasma 
membrane, receptors bind lipoprotein ligands, and internalization occurs by 
endocytosis via clathrin-coated pits. After receptor-ligand complexes are taken up 
into clathrin-coated pits, they are delivered to endosomes. In the endosomes the low 
pH-environment triggers release of the bound lipoprotein particles (see below). 
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Subsequently, the receptors return to the cell surface in a process called receptor 
recycling (Brown and Goldstein 1986; Maxfield and McGraw 2004; Beglova and 
Blacklow 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The LDLR is the key component in the feedback-regulated maintenance of 
cholesterol homeostasis in the body (Goldstein, Brown et al. 1985). Cholesterol 
derived from LDL and its intracellularly generated oxidated derivatives mediate a 
complex series of feedback control mechanisms that on the one hand provide the 
cells with cholesterol and on the other hand protect the cell from overaccumulation of 
cholesterol. 
First, sterols suppress the activities of two key enzymes in cellular cholesterol 
biosynthesis, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase and HMG-CoA 
reductase. The second step is that cholesterol activates the cytoplasmic enzyme 
acyl-CoA:cholesterol acyltransferase (ACAT), which allows the cell to store spare 
Figure 6. Cellular itinerary of the LDLR. 
(1) Synthesis of the receptors occurs at the ribosomes and they are folded in the ER. (2) 
Receptors are glycosylated in the Golgi network and transported to the cell surface. (3) 
LDLRs bind ligands at the plasma membrane. (4) Internalization takes place via clathrin-
coated pits, which deliver receptor-ligand complexes to endosomes. (5) The lipoproteins 
are released and the LDLRs are recycled back to the cell surface [figure 2 from (Beglova 
and Blacklow 2005)] 
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Figure 7. Sequential steps in the LDLR pathway in mammalian cells.  
Details are described in the text. HMG CoA reductase, 3-hydroxy-3-methylglutaryl-CoA 
reductase; ACAT, acyl-CoA:cholesterol acyltransferase. LDL, low-density lipoprotein;  
Vertical arrows indicate the direction of the regulatory effects (Brown and Goldstein 1979). 
cholesterol in re-esterified form. Third, the synthesis of new LDLRs is suppressed to 
prevent cholesterol overloading (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
Mammalian cells are able to survive without exogenously derived cholesterol, 
because they can synthesize cholesterol from acetyl-CoA. When LDL is available, 
most cells primarily use the LDLR to import LDL cholesterol and keep their own 
synthetic activity suppressed in order to maintain cholesterol homeostasis. Thereby, 
a constant level of cholesterol in the cells is sustained, while the external cholesterol 
supply can undergo large fluctuation (Schneider and Nimpf 2003). 
 
 
Other members of the LDL receptor gene family 
 
The most important members of the growing LDLR superfamily are listed below 
(table 1) in order of their discovery, and the structural organization of these receptors 
is shown in Fig. 8. The avian counterpart of each receptor is indicated in the table, 
because the chicken is the working model and the chicken receptors also 
demonstrate the high conservation of the key players in lipid metabolism. 
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Human Chicken 
LDLR 
Low-density lipoprotein receptor (Goldstein and 
Brown 1974) 
LDLR 
Low-density lipoprotein receptor 
(Hummel, Lynn et al. 2003) 
LRP2/megalin/gp330 
Low-density lipoprotein receptor-related protein 
2 (Kerjaschki and Farquhar 1982) 
LRP2/megalin 
Low-density lipoprotein receptor-related 
protein 2 (currently characterized in our 
laboratory) 
LRP1/ α2-macroglobulin receptor 
Low-density lipoprotein receptor-related protein 
(Herz, Hamann et al. 1988) 
LRP1 
Low-density lipoprotein receptor-related 
protein 1 (Stifani, Barber et al. 1991; 
Nimpf, Stifani et al. 1994) 
VLDLR 
Very-low-density lipoprotein receptor 
(Takahashi, Kawarabayasi et al. 1992) 
LR8 
LDLR relative with eight ligand binding 
repeats (Bujo, Hermann et al. 1994) 
LR11/sorLA 
LDLR relative with 11 binding repeats/ sorting 
protein-related receptor (Yamazaki, Bujo et al. 
1996; Morwald, Yamazaki et al. 1997) 
LR11 
LDLR relative with 11 binding repeats 
(Morwald, Yamazaki et al. 1997) 
ApoER2/LRP8 
Apolipoprotein E receptor type 2 (Kim, Iijima et 
al. 1996) 
LR7/8B  
Chicken homologue of ApoER2 (Novak, 
Hiesberger et al. 1996; Brandes, Novak 
et al. 1997) 
LRP3, 4, 5, and 6 
LDLR related protein -3, -4, -5, and -6 (Herz and 
Bock 2002; Strickland, Gonias et al. 2002) 
LRP4 (3, 5, 6 not characterized yet) 
LDLR related protein-4 (MEGF7) 
(Tomita, Kim et al. 1998) 
LRP1B/LRP-DIT 
Low-density lipoprotein receptor-related protein 
1 
Lipoprotein receptor-related protein-deleted in 
tumors (Liu, Musco et al. 2000) 
LRP-DIT 
Lipoprotein receptor-related protein-
deleted in tumors (found in the chicken 
cell lines DT40 and DKO-R cells, 
unpublished) 
 
 
Table 1. Members of the human LDLR gene family and their homologues in the chicken. 
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Figure 8. Domain structures of the members of the LDL receptor family. 
For a detailed description refer to the text (Andersen and Willnow 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VLDL receptor (VLDLR) 
 
The VLDLR was discovered in 1992 by Takahashi et al (Takahashi, Kawarabayasi et 
al. 1992). A striking feature of the VLDLR is its structural similarity to the LDLR, 
except that the VLDLR ligand binding domain contains an additional LA repeat, which 
apparently preceeds the 7 present in the LDLR. This view is supported when the two 
genes are aligned. The VLDLR shows an amazing degree of conservation among 
different species. The mammalian VLDLR exists in variant forms, containing an O-
linked sugar domain or not, arising from differential splicing (Magrane, Reina et al. 
1998). The predominant expression sites are heart, skeletal muscle, and adipose 
tissue. Unlike the LDLR, which is expressed in most cells and notably in the liver, the 
expression of the VLDLR in the liver is virtually absent (Takahashi, Kawarabayasi et 
al. 1992). Despite the structural similarity between the LDLR and VLDLR, their ligand 
binding properties differ considerably. The LDLR binds apoE- and apoB-containing 
lipoproteins, whereas the VLDLR binds to apoE-containing lipoproteins, but does not 
bind to LDL. This might be because of the fact that it does not recognize apoB100 
(Mikhailenko, Considine et al. 1999). Another difference to the LDLR is that the 
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VLDLR level is not regulated by cellular sterols, but seems to be influenced by 
hormones such as estrogen and thyroid hormone. 
The tissue distribution of the VLDLR is highly suggestive of a role in triacylglycerol 
transport into metabolically active tissues, although uptake of high amounts of VLDL 
by this receptor has not been shown. 
It now has been convincingly demonstrated that the VLDLR plays a role in a signal 
transduction cascade that controls neuronal migration and positioning. VLDLR binds 
the extracellular matrix-associated protein Reelin, and this interaction is needed for 
the downstream induction of tyrosine-phosphorylation of Disabled-1 (Dab1). Thus, a 
Reelin-VLDLR-Dab1 pathway is proposed that regulates neuronal positioning in 
cortex, hippocampus, and cerebellum during development (Hiesberger, Trommsdorff 
et al. 1999; Trommsdorff, Gotthardt et al. 1999). 
 
 
LR8, the avian VLDLR homologue 
 
Oviparous (egg-laying) species express LR8 (Fig. 9), which is highly homologous to 
the mammalian VLDLR (Bujo, Hermann et al. 1994). In contrast to mammals, the 
major function of LR8 in avian species is well established. Large amounts of yolk 
precursors, mainly VLDL and vitellogenin (VTG), are synthesized by the liver, 
transported via the circulation and subsequently deposited into the growing oocyte. 
This process, commonly known as vitellogenesis, is pivotal for reproduction in these 
species, because the developing embryo depends on the yolk components stored in 
the oocyte. The massive uptake into growing oocytes in the ovary of VLDL and VTG 
(approximately 12g during vitellogenesis) from the plasma is achieved by receptor-
mediated endocytosis (Schneider 1995). LR8 binds to VLDL, VTG, α2-macroglobulin, 
and lactoferrin (Bujo, Lindstedt et al. 1995). The receptor is specific for the apoB 
moiety of the VLDL particle, whereas apolipoprotein VLDL-II, a powerful lipoprotein 
lipase inhibitor (the only other major apolipoprotein present on VLDL from laying 
hens), is not involved in receptor binding (Nimpf, George et al. 1988). 
The receptor gene is located on the chicken sex chromosome Z, and the protein is 
expressed almost exclusively in oocytes and at much lower levels in heart and 
skeletal muscle. Similar to the situation for the mammalian VLDLR, the chicken 
expresses two forms of LR8: in somatic cells LR8 is expressed as the larger isoform, 
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Figure 9. Schematic structure of the chicken VLDLR homologue LR8. 
The domains of LR8 are: ligand binding domain with eight LA-repeats; an EGFP homology 
domain consisting of two EGF repeats (A, B) followed by a six-bladed beta-propeller and an 
adjacent C-terminal EGF repeat (C); an O-linked sugar domain that is either present (in the 
isoform LR8+) or absent (in the isoform LR8-); a short transmembrane domain; and finally, a 
short cytoplasmic tail containing an internalization motif (NPxY) required for endocytosis. The 
point mutation responsible for the R/O phenotype located in the EGF repeat C is indicated with 
an asterisk. 
LR8+, which contains the O-linked sugar domain, whereas the oocyte expresses the 
LR8- isoform lacking the O-linked sugar domain (Bujo, Lindstedt et al. 1995). 
 
 
The mutant restricted ovulator (R/O) chicken strain 
 
The key role of LR8 in oocyte development in egg-laying species is also shown by a 
genetic model in which the receptor function is disrupted. The functional absence of 
the receptor, caused by a point mutation, which changes residue 682 in the lr8 locus 
from cysteine into a serine (Fig. 9), leads to an inability of oocytes to take up yolk, 
and therefore to enter the rapid growth phase. The consequence is the absence of 
egg laying and the failure to produce offspring. The deficiency to deposit VLDL and 
VTG, which are produced at normal levels in the liver, into their oocytes leads to 
severe hyperlipidemia and features of atherosclerosis in the mutant females, thus 
being an ideal model for studies of atherogenesis (Nimpf, Radosavljevic et al. 1989; 
Bujo, Yamamoto et al. 1995). 
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Apolipoprotein E receptor 2 (apoER2) 
 
Apolipoprotein E receptor 2 (apoER2) is a member of the LDLR gene family, found 
mainly in brain, placenta, and testis, which acts in endocytosis and in signal 
transduction (Kim, Iijima et al. 1996). In particular, apoER2 functions as a cellular 
receptor for Reelin, a signaling factor that regulates neuronal migration processes in 
the embryonic brain. ApoER2-deficient mice display abnormal layering of neurons in 
the cortex, hippocampus, and cerebellum, and these mice also suffer from male 
infertility (Hiesberger, Trommsdorff et al. 1999; Trommsdorff, Gotthardt et al. 1999). 
In a recent study apoER2 has been identified to have a crucial role in sperm 
maturation, in particular in the acquisition and development of sperm motility 
(Andersen, Yeung et al. 2003). 
 
 
LR7/8B, the chicken homologue of apoER2 
 
The human apoER2 and LR7/8B in chicken are not two distinct new members of the 
LDLR gene family, but rather are variants derived from the same gene (Novak, 
Hiesberger et al. 1996; Brandes, Novak et al. 1997). LR7/8B in chicken is apparently 
only expressed in brain, which is in sharp contrast to other members of the LDLR 
gene family. The expression can be allocated to two different types of cells: first, to 
large neurons and second, to cells constituting brain barriers such as endothelial 
cells of blood vessels. LR7/8B was shown to be a receptor for activated α2-
macroglobulin (Stockinger, Hengstschlager-Ottnad et al. 1998). 
 
 
Mammalian and chicken LRP1/ α2-macroglobulin receptor  
 
LRP1 is a multiligand receptor involved in a variety of independent processes such 
as lipoprotein metabolism (binding mainly apoE-enriched lipoproteins) and 
extracellular proteinase homeostasis (Herz, Hamann et al. 1988; Strickland, Kounnas 
et al. 1995). The latter function is mediated by α2-macroglobulin (α2M), a 
multifunctional proteinase inhibitor. α2M forms complexes with a variety of 
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proteinases that are rapidly removed from the circulation by specifically binding to 
hepatic LRP1. The cytoplasmic tail harbours, additionally to the two NPxY motifs, a 
YxxL motif, which appears to be the dominant determinant for internalization (Li, 
Marzolo et al. 2000). 
Recently, it has been shown that LRP1 inhibits complement protease expression by 
suppressing cell signaling through the IκB kinase (IKK)/nuclear factor-κB (NF-κB) 
pathway. NF-κB is a ubiquitous regulator of inflammation and cell survival in diverse 
cell types. This ability of LRP1 to regulate cell signaling represents a novel 
mechanism by which LRP1 controls cell physiology (Gaultier, Arandjelovic et al. 
2008). 
The avian LRP1/ α2-macroglobulin receptor (α2MR) shows an overall identity of 83% 
with human LRP1/α2MR (Stifani, Barber et al. 1991; Nimpf, Stifani et al. 1994). It is 
expressed in somatic cells, and it was shown that LRP1 does not metabolize 
chylomicron remnants. LRP1 binds Ca2+, α2M, and VTG. These results indicate that 
avian LRP1 plays a crucial role in the reproduction of oviparous species, i.e. in 
vitellogenesis. 
 
 
LR11/SorLA and its chicken counterpart 
 
LR11 is a complex seven-domain mosaic protein containing a cluster of 11 ligand 
binding repeats and a domain with homology to VPS10, a yeast receptor for vacuolar 
protein sorting. It has been first identified in rabbit and was subsequently found in 
chicken. The mammalian receptor is highly expressed in brain and is present at 
significant levels in liver, adrenal glands, and testis (Yamazaki, Bujo et al. 1996; 
Morwald, Yamazaki et al. 1997). 
LR11 is sterol insensitive; this fact suggests functions other than in lipoprotein 
metabolism, but the expression of LR11 in tissues with active cholesterol metabolism 
should not be overlooked. 
Thus, the chicken, human, rabbit LR11 and LR7/8B in chicken and mouse (Novak, 
Hiesberger et al. 1996) are proposed to be members of a hitherto unknown branch of 
the LDLR gene family, which may participate in brain-specific physiological 
processes. 
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A few years ago, it was reported that LR11 acts as neuronal sorting receptor that 
binds amyloid precursor protein (APP) and regulates its trafficking and proteolytic 
processing into amyloid β-peptide (Aβ), the process causative to Alzheimer’s disease 
(Andersen, Reiche et al. 2005; Dodson, Andersen et al. 2008). 
 
 
LRP2, previously named gp330 and megalin 
 
LRP2, originally identified as a pathogenic antigen of Heymann nephritis, is a 
member of the LDLR gene family. LRP2 is a 600kDa type I transmembrane protein 
(Kerjaschki and Farquhar 1982) with a large, amino-terminal extracellular domain, a 
single transmembrane domain, and a short carboxy-terminal cytoplasmic tail 
containing 3 NPxY motifs, which mediate clustering in clathrin-coated pits 
(Christensen and Birn 2002). LRP2 is a multiligand, endocytic receptor, which is 
localized to the plasma membrane and the endocytic apparatus of epithelial cells 
including the small intestine, renal proximal tubule, and the visceral yolk sac 
(Kozyraki and Gofflot 2007). Ligands for LRP2 are vitamin-binding proteins like 
vitamin-D-binding protein, apolipoproteins like apoB, apoE, apoJ (clusterin), steroid 
hormones, enzymes like lipoprotein lipase, immune- and stress-response-related 
proteins like Ig light chain, drugs and toxins, and other carrier proteins such as 
albumin, lactoferrin, and haemoglobin. LRP2 also binds receptor-associated protein 
(RAP), which is involved in folding of the receptor (Christensen and Birn 2002). 
Besides this, LRP2 is a calcium-sensing protein (Christensen, Gliemann et al. 1992) 
that interacts with Cubilin (Fig. 4). Essential functions are associated with this 
receptor-complex, like ileal absorption of vitamin B12, renal reabsorption and handling 
of proteins, vitamins, lipids, and iron, embryonic nutrition and development (Moestrup 
and Verroust 2001; Kozyraki and Gofflot 2007). In the chicken, LRP2 has not been 
extensively characterized, but there are unpublished data showing that LRP2 is 
present in the chicken yolk sac and in the embryonic and adult kidney (Plieschnig 
2008). 
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LRP1B/LRP-DIT 
 
LRP1B has been initially discovered as a putative tumor suppressor, involved in non-
small cell lung carcinoma (Liu, Musco et al. 2000), and was therefore also designated 
LRP-DIT (LRP deleted in tumor). LRP1B shows the highest homology to LRP1, 
containing one additional ligand binding repeat and an insertion of 33 amino acids in 
the cytoplasmic domain compared to LRP1. Although the biological functions of 
LRP1B have not been clearly defined, LRP1B has been shown to bind several LRP1 
ligands, and therefore may also play roles in a wide variety of cellular processes. 
Despite the similarities between LRP1 and LRP1B, the endocytosis rate of LRP1B is 
markedly slower (Liu, Li et al. 2001; Knisely, Li et al. 2007). This difference in 
endocytic rate could have important implications for the biological and tumor 
suppressor functions of LRP1B. 
A predicted sequence (XM_422146.2) in the NCBI database likely encodes a 
putative chicken LRP1B. 
 
 
Interaction of the LDLR with apolipoproteins 
 
Apolipoprotein B (apoB) 
 
Apolipoprotein B (apoB) is a large amphipathic protein that serves an essential role in 
the assembly and secretion of lipids, including triglycerides and cholesterol of both 
dietary and endogenous source, and also in the intravascular transport and receptor-
mediated uptake and delivery of distinct classes of lipoproteins. The importance of 
apoB ranges from the absorption and processing of dietary lipids to the regulation of 
circulating lipoprotein levels (Davidson and Shelness 2000; Olofsson and Boren 
2005). 
In mammals, apoB circulates in two distinct forms, apoB100 and apoB48. Both forms 
are encoded by a single apoB gene. The molecular mechanism responsible for the 
production of the two isoforms involves a site-specific mRNA modification by 
deamination, referred to as C-to-U editing (see Fig. 10). 
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Figure 10. mRNA editing of the apoB gene. 
In mammals, the apoB gene is expressed in hepatocytes and intestinal epithelial cells. 
However, in liver cells, its product is a 500 kDa protein called apoB100, whereas in intestinal 
cells, its product is a smaller protein called apoB48. The apoB100 is translated from unedited 
RNA, but the apoB48 is synthesized from mRNA, whose sequence has been altered by a 
specific enzyme. This enzyme changes codon 2153, CAA, in the middle of the original mRNA 
to the stop codon UAA, thereby causing early termination of the protein synthesis. 
(http://www.web-books.com/MoBio). 
Figure 11. Organization of apoB100 on the LDL 
particle. 
ApoB100 (yellow band) spans the entire 
circumference of the LDL particle and there is an 
interaction between the C-terminal part and the N-
terminal part. The C-terminal end folds back over the 
preceding portion of the molecule, a folding that is 
dependent on the interaction between amino acid 
3500 and 4369, which prevents the C-terminal part 
from sliding over the LDLR-binding site (site B amino 
acids 3359-3369). The proteoglycan-binding sites A 
and B (B is also the LDLR-binding site) are indicated 
(Olofsson and Boren 2005). 
 
 
 
 
 
 
 
 
 
 
 
ApoB100 (Fig. 11) representing the full-length protein of about 500kDa, is exclusively 
expressed in the liver and is required for the synthesis and secretion of very-low-
density lipoprotein (VLDL). ApoB100 is the major protein component of low-density 
lipoprotein (LDL), a catabolic product of VLDL, and contains the domain required for 
the interaction with the LDLR (Young 1990; Davidson and Shelness 2000). 
ApoB100 also plays a central role in the development of atherosclerosis. Two 
proteoglycan-binding sequences in apoB100 have been identified, which are 
important for retaining the lipoprotein in the intima of the artery. Retention is essential 
for the development of atherosclerotic lesions (Glass and Witztum 2001; Skalen, 
Gustafsson et al. 2002; Olofsson and Boren 2005). 
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ApoB48 corresponds exactly to the N-terminal 48% of apoB100, has a size of about 
240kDa and is synthesized by the intestinal epithelial cells. In humans, apoB48 
circulates in association with chylomicrons (CM) and chylomicron remnants (CR). 
Under normal circumstances, plasma residence time of chylomicrons in humans is 
very short (minutes to hours) compared with that of LDL (~two days). Thus apoB48 
can be viewed as a crucial adaptation by which dietary lipids are delivered from small 
intestine to liver. In contrast, apoB100 can be regarded as participating in the 
transport and delivery of endogenous plasma cholesterol (Young 1990; Davidson 
and Shelness 2000). 
 
 
Apolipoprotein E (apoE) 
 
Apolipoprotein E (apoE) is a 34kDa protein consisting of 299 amino acids. Its 
complete amino acid sequence has been published in 1982 (Rall, Weisgraber et al. 
1982), and is associated with VLDL, β-VLDL, chylomicrons, and less frequently with 
HDL (Mahley 1988). ApoE, which stabilizes lipoprotein particles, plays an important 
role in regulating cholesterol homeostasis as well as in regulating plasma triglyceride 
clearance through its interaction with members of the LDLR gene family (Mahley 
1988). 
ApoE-containing lipoproteins are the principal lipid transport vehicles in cerebrospinal 
fluid. Another feature of apoE is that its expression is induced at high concentration in 
peripheral nerve injury and appears to play a key role in repair by redistributing lipids 
to regenerating axons (Pitas, Boyles et al. 1987; Mahley and Huang 1999). 
ApoE is also involved in immunoregulation and host defense. ApoE improves 
resistance to Klebsiella pneumoniae and Listeria monocytogenes infection and 
inhibits malaria sporozoite invasion of hepatocytes. The mechanisms of immune 
modulation by apoE are diverse and complex, and the impact of apoE on human 
immunity is poorly understood (Mahley and Rall 2000; Li, Thompson et al. 2008). 
ApoE is a ligand for LDLR, VLDLR, apoER2, LRP1, and LRP2. Unlike other 
apolipoproteins, apoE is not only synthesized in the liver, but also in brain, spleen, 
lung, kidney, smooth muscle cells, ovaries, and in macrophages (Lin, Xu et al. 1986; 
Li, Thompson et al. 2008). ApoE (Fig. 12) is composed of two structurally and 
functionally independent domains, a 22kDa N-terminal domain (residues 1-191) that 
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is recognized by receptors and a 10kDa C-terminal domain (residues 218-299) with 
high affinity for lipid, responsible for the association of apoE with lipoproteins 
(Aggerbeck, Wetterau et al. 1988; Wetterau, Aggerbeck et al. 1988; Morrow, Segall 
et al. 2000). This amphipathic α-helical lipid-binding domain allows apoE to switch 
between a lipoprotein-bound and a lipid-free state. The LDLR-binding region (in the 
vicinity of residues 136-150) of apoE, located in helix 4 (Fig. 12), is enriched in basic 
amino acids (lysyl- and arginyl-residues) that are thought to interact with acidic 
residues in the ligand binding domains of members of the LDLR gene family 
(Weisgraber 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Full receptor-binding activity also requires an arginine at position 172, which is 
located in the hinge region (see Fig. 12) (Morrow, Arnold et al. 2000). Lipid-free apoE 
does not bind with high affinity to the LDLRs, and therefore apoE must be associated 
with lipids. Although the N-terminal domain binds lipid, the principal lipoprotein-
binding elements lie in the C-terminus at residues 244-272 (Hatters, Peters-Libeu et 
al. 2006). 
ApoE is polymorphic, which influences its functional and structural properties. The 
three common allelic isoforms, apoE2, apoE3, and apoE4, differ at positions 112 and 
Figure 12. Model of the structure of lipid-free apoE. 
The N-terminal domain consists of a four helix-bundle (1, red; 2, blue; 3, green; 4, yellow). 
The LDLR-binding region resides on helix 4. The hinge region, connecting N- and C-
terminus, contains Arg172 for high-affinity binding to the LDLR. The N-terminus also 
contains the polymorphic positions 112 and 158 that distinguish the three common isoforms. 
The C-terminal domain (gray) contains the main lipoprotein-binding elements [modified from 
(Hatters, Peters-Libeu et al. 2006)]. 
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Table 2. Prevalence of the human apoE isoforms and their key differences.  
The table is modified from (Hatters, Peters-Libeu et al. 2006). 
158. ApoE3, the most common isoform, contains cysteine and arginine, whereas 
apoE2 has two cysteines, and apoE4 has two arginines at these positions (see Fig. 
13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional 
differences 
 
Isoform 
Average 
allelic 
frequency 
(%) 
Amino 
acid 
variation 
(residue) 
 
112  158 
LDLR 
affinity 
Lipoprotein-
binding 
preference 
Associated 
disorders 
ApoE2 7 Cys   Cys low HDL 
Type III 
hyperlipoproteinemia 
ApoE3 78 Cys   Arg high HDL none known 
ApoE4 15 Arg   Arg high VLDL, LDL 
Alzheimer’s disease; 
atherosclerosis 
 
 
 
 
ApoE3 and apoE4 bind the LDLRs with similar affinity, but the binding of apoE2 is 
50- to 100-times weaker (see table 2). This binding defect results in delayed 
receptor-mediated clearance of lipoproteins from the circulation and in combination 
with genetic, hormonal or environmental influences results in familial type III 
hyperlipoproteinemia. Type III hyperlipoproteinemia is a genetic disorder 
characterized by elevated plasma cholesterol and triglyceride levels and accelerated 
coronary artery disease. The cysteine at position 158 leads to a new salt bridge 
between Arg150 and Asp154. This salt bridge alters the conformation of Arg 150 with 
Figure 13. Scheme of the 3 common allelic 
isoforms of apoE. 
ApoE2 contains 2 cysteines on positions 112 
and 158, apoE3 comprises cysteine and 
arginine, and apoE4 has two arginines. 
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respect to the other basic residues in the receptor-binding region (amino acids 136-
150), reducing the ability of apoE2 to interact effectively with the LDL receptor (Dong, 
Parkin et al. 1996; Hatters, Peters-Libeu et al. 2006). 
The most pronounced pathological effect attributable to the apoE polymorphism is 
the association of apoE4 with common late-onset familial and sporadic forms of 
Alzheimer’s disease (AD). ApoE4 is a major risk factor for AD, accounting for 40-60% 
of the genetic variability observed in the disease. Its presence not only increases the 
risk but also lowers the age of onset, of AD (Corder, Saunders et al. 1993; Saunders, 
Strittmatter et al. 1993). The biochemical mechanism by which apoE4 increases the 
risk of AD is unknown, but AD patients who are homozygous for the apoE4 allele 
exhibit more highly developed senile plaques at autopsy than other AD patients. 
Thus, because neuronal pathology is a characteristic of AD (Nathan, Bellosta et al. 
1994), apoE4 may contribute to the pathogenesis of AD. 
 
 
Binding of apoE to the LDL receptor 
 
The ligand binding domain of the LDLR contains seven imperfect repeats of a 40-
amino acid cysteine-rich sequence (see Fig. 5). The LDLR has been shown to bind 
two different proteins, apoB100 and apoE. LDL contains a single copy of apoB100, 
and β-migrating VLDL (β-VLDL) contains apoB100 or apoB48 and multiple molecules 
of apoE. 
Each repeat comprises clustered negative charges that have been postulated as 
ligand binding sites. An early study has gained insights in the ligand binding domain 
of the LDLR via mutational analysis (Esser, Limbird et al. 1988). It was shown that 
the seven repeats in the ligand binding domain of the LDLR are functionally not 
equivalent. Deletion of repeat 1 (∆R1) does not change the binding of LDL or β-VLDL 
(see Fig. 14). Repeat 2 plus 3 (∆R1-3) and repeat 6 plus 7 (∆R6, 7) are required for 
maximal binding of LDL, but not of β-VLDL. Repeat 5 of the ligand binding domain 
seems crucial for binding of both ligands, as shown with deletion of repeats 1-5 (Fig. 
14). 
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The most definitive evidence for a functional difference between repeats arises if 
tyrosine is substituted for aspartate in the negatively charged cluster of serine-
aspartate-glutamate (SDE). This substitution in repeat 5 (Asp206) nearly abolishes the 
binding of β-VLDL as well as of LDL (see Fig. 15). The same mutation in repeat 6 
(Asp245) had no effect on β-VLDL binding, and LDL binding is only reduced. In repeat 
1 (Asp36) this substitution has no effect. These data suggest that repeat 5 plays a 
much more critical role in binding than do repeats 1 or 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LDL binding β-VLDL Binding 
100% 100% 
100% 86% 
71% 108% 
31% 71% 
0% 0% 
18% 83% 
Figure 14. Deletion mutations in the ligand binding domain of the LDL receptor. 
Normal: all 7 repeats of the ligand binding domain are present; the repeats remaining in 
five deletion mutations are depicted below the normal ligand binding domain, and the 
individual mutations are named on the left. The results are presented as a percentage of 
the LDL/β-VLDL binding values observed in cells transfected with the normal cDNA 
[modified from (Esser, Limbird et al. 1988)]. 
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Figure 15. Effects of mutations in residues 1-292 of the LDLR on ligand binding activity. 
The mean values obtained at saturating concentrations of 125I-LDL or 125I-β-VLDL for a given 
mutant LDLR are plotted in histogram form and expressed as percent of control. The repeats 
in which the mutations occur are indicated on the left (Esser, Limbird et al. 1988). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A recent investigation revealed that the LA4-5 two-repeat pair is sufficient for binding 
of apoE-containing ligands, and that LA5 alone is not sufficient to recognize these 
ligands. It has been observed that more than one receptor-binding site in its lipid-
activated conformation is required to bind to the LDLR with high affinity (Fisher, 
Abdul-Aziz et al. 2004). 
In another study, swapping and replacing specific LA repeats within the ligand 
binding module of the LDLR has been performed. They show that LA5 must not only 
be present, but must exist in the correct context with respect to other LA repeats 
within the ligand binding domain. The data indicate that the sequential order of LA 
repeats plays a key role in the binding properties of the LDLR (Yamamoto and Ryan 
2009). 
The LA5 repeat is particularly important for LDL binding and release. LA5 contains 40 
residues, including six cysteines that form three disulfide bridges, and four acidic 
residues, involved in binding of a structural calcium ion. The calcium ion is 
structurally and functionally important. In its absence the recombinant LA5 repeat 
cannot form native disulfide bonds, and LDL binding is impaired at low Ca2+ 
concentrations (Blacklow and Kim 1996). 
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Low pH and low Ca2+ concentration decrease the stability of LA5, which triggers its 
unfolding in the endosome, thus providing a mechanism for LDL release from the 
receptor (see Fig. 16, upper pathway) (Arias-Moreno, Velazquez-Campoy et al. 
2008). 
In Fig. 16, the lower pathway represents the currently accepted view of pH-induced 
release of LDL from the LDLR. The LDLR forms an “open conformation” at neutral 
pH, exposing LA repeats for LDL binding. The acidic environment of endosomes 
triggers the LDLR to adopt the “closed conformation”. At endosomal pH, the β–
propeller, rather than LDL, associates with LDL binding repeats, resulting in 
displacement of LDL (Rudenko, Henry et al. 2002; Debose-Boyd 2004). 
 
 
 
 
 
Figure 16. Proposal of a new mechanism for the release of LDL particles in the 
endosome based on the instability at endosomal low pH and low Ca
2+
 concentrations. 
Lower pathway: The conventional model for low pH-induced release of LDL from the LDLR. 
Upper pathway: A new proposal, which shows that under low pH and low Ca2+ 
concentration, LA5 is unable to bind Ca2+ and appears in an unfolded conformation not 
expected to bind LDL particles (Arias-Moreno, Velazquez-Campoy et al. 2008). 
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Adaptor proteins in endocytosis 
 
Endocytosis, a highly coordinated process, plays a key role in cell homeostasis and 
signaling (Evans and Owen 2002). Through endocytosis, cells internalize plasma 
membrane components and nutrients in response to environmental cues or 
intracellular signals, control the composition of the plasma membrane, downregulate 
signaling receptors, and recycle transmembrane proteins (Sorkin 2004; Szymkiewicz, 
Shupliakov et al. 2004). Among the different forms of endocytosis, the most 
extensively studied and best characterized at the molecular level is the clathrin-
mediated endocytosis (CME) pathway (Fig. 17) (Mousavi, Malerod et al. 2004), in 
which clathrin-coated vesicles (CCV) are formed at the plasma membrane. This 
pathway requires the action of endocytic adaptor proteins, which select receptors for 
internalization. These adaptor proteins recruit their cargo into clathrin-coated pits 
(CCPs) by binding to clathrin and to internalization signals within the cytoplasmic 
regions of the receptor, which in the case of LDLR family members is the FxNPxY 
motif. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The designation “endocytic” adaptors is generally reserved for proteins that bind to 
the lipid phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) and also to clathrin 
and to internalization motifs. There are two major classes of endocytic adaptors: the 
classical (multimeric) adaptors like adaptor protein 2 (AP2) (Fig. 18), adaptor protein 
Figure 17. Clathrin-mediated endocytosis. 
Transmembrane proteins destined to endosomes are selectively accumulated in clathrin-coated 
pits at the plasma membrane and rapidly internalized in clathrin-coated vesicles. The 
recognition of specific sequence motifs in transmembrane cargo by coated-pit proteins confers 
specificity on the endocytic process. Interaction of membrane cargo with the clathrin adaptor 
protein complex AP2 is the major mechanism of cargo sorting into coated pits (Puertollano 
2004). 
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3 (AP3), and the alternative (monomeric) adaptors, also known as clathrin-associated 
sorting proteins (CLASP) like epsins, Dab2, ARH, and Numb (Traub 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recently, the identification of the molecular defect responsible for a recessive form of 
hypercholesterolemia that clinically resembles FH provided new insights into LDLR 
physiology. This disorder, called Autosomal Recessive Hypercholesterolemia (ARH), 
is caused by mutations in the adaptor protein ARH, also termed LDLR adaptor 
protein 1 (LDLRAP1) (Garcia, Wilund et al. 2001). ARH is a newly discovered 
adaptor protein required for the efficient activity of LDLR in selected tissues and for 
the efficient internalization of the LDL-LDLR complex (Eden, Patel et al. 2002). It has 
been shown that ARH binds to the LDLR cytoplasmic tail as well as to two 
components of the clathrin-coated pit, the heavy chain of clathrin (Fig. 19), and the 
β2-subunit of the adaptor protein AP2 (He, Gupta et al. 2002). 
 
 
 
 
 
 
 
 
ARH binds the FxNPxY motif in the cytoplasmic tails of the LDLR family members 
and PtdIns(4,5)P2 via the N-terminal phosphotyrosine binding (PTB) domain. ARH 
Figure 18. Schematic representation of AP2. 
 AP2 is a tetramer, which contains large (α and β2 
adaptins), medium (µ2), and small (σ2) subunits. 
The large subunits can be subdivided into an N-
terminal (trunk) domain and a globular C-terminal 
(appendage) region, which are connected via a 
hinge. AP2 binds clathrin through the β2-hinge and 
the appendage domains. Alternative adaptors and 
regulatory proteins are bound via the α- and β2-
appendage domains. The µ2 domain functions in 
the recognition of sorting motifs that are present in 
the cytosolic tail of different cargo proteins. 
PtdIns(4,5)P2 binding sites are present in both α- 
and µ2-subunits (Puertollano 2004). 
Figure 19. Schematic drawing of clathrin. 
The assembly unit of clathrin, commonly referred to 
as the “triskelion”, consists of three heavy chains 
and three light chains that oligomerize to form 
three-dimensional polygonal lattices, or cage-like 
structures (Puertollano 2004). 
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also binds to clathrin and to AP2 via a C-terminal clathrin-box (aa 212-216: LLDLE) 
and an AP2 binding region (aa 249-276: WELDDGLDEAFSRLAQSRTNPQVLDTGL) 
(Fig. 20) (Mishra, Watkins et al. 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The adaptor protein Numb 
 
Numb is an evolutionarily conserved protein identified two decades ago as a cell fate 
determinant in the nervous system of Drosophila. Numb was reported to regulate cell 
fate by its asymmetrical segregation in daughter cells during cell division (Uemura, 
Shepherd et al. 1989; Rhyu, Jan et al. 1994). In contrast, a Numb homologue, 
identified in chickens, localizes basally rather than apically in dividing avian 
neuroepithelial cells. Thus, chicken Numb would be segregated to the basal daughter 
rather than the apical daughter, when a neuroepithelial cell divides with a vertical 
spindle (Wakamatsu, Maynard et al. 1999). 
Numb contains two protein-protein interaction domains, a phosphotyrosine-binding 
(PTB) domain and a proline-rich region (PRR) that function as a Src-homology-3 
(SH3)-binding domain. In Drosophila only one form of Numb has been identified. In 
contrast, in mammals, four different isoforms are known. Mammals produce these 
four isoforms (Fig. 21) through alternative splicing. The variants differ in the length of 
their PTB (lacking or containing an insert) and PRR (lacking or containing an insert) 
domains (Verdi, Schmandt et al. 1996; Dho, French et al. 1999). 
 
 
Figure 20. Scheme of the human adaptor protein ARH. 
For details see the text. PTB, phosphotyrosine binding domain; AP2, 
adaptor protein 2  
AP2 binding region, WELDDGLDEAFSRLAQSRTNPQVLDTGL; 
Clathrin box, LLDLE; 
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Figure 21. Four different isoforms of mouse Numb. 
PTB, phosphotyrosine-binding domain; PTBi, PTB with insert; PRR, proline-rich region; 
PRRi, PRR with insert; 
The insert in the PTB domain is 100% conserved in mammals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The PTB domain of Numb is evolutionarily and most closely related to that of ARH. 
The Numb PTB domain is 31% identical (46% similar) to the human ARH PTB 
domain (Mishra, Watkins et al. 2002). All Numb proteins contain the NPF and DPF 
motifs critical for interaction with proteins containing the Eps15 homology (EH) 
domain and with the clathrin protein AP2. It has been shown that the in vivo binding 
of Eps15 to Numb is most likely mediated by an EH-NPF interaction, and that an 
intact NPF is necessary but not sufficient for binding (Salcini, Confalonieri et al. 
1997). The interaction of Numb with the AP2 complex is dynamically regulated by 
phosphorylation of Numb. It was suggested that phosphorylation-dependent binding 
of 14-3-3 protein may regulate AP2 binding to Numb (Tokumitsu, Hatano et al. 2006). 
Numb can associate with CCPs, vesicles, and endosomes, suggesting that it 
functions as an endocytic adaptor protein (Santolini, Puri et al. 2000; Berdnik, Torok 
et al. 2002). 
A recent study has found that phosphorylation by adaptor-associated kinase 1 
(AAK1), which is an endocytic kinase homologue to the Drosophila Numb-associated 
kinase, may regulate Numb interaction with the coat protein machinery and that 
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AAK1-dependent phosphorylation may increase Numb affinity for AP2 (Sorensen and 
Conner 2008). 
The PTB domain of Numb seems to be required for the interaction with Sanopodo, 
which is a four-pass transmembrane protein that regulates Notch signaling in the 
central nervous system, in vivo. The results in this study establish Numb- and α-
Adaptin-dependent endocytosis of Sanopodo as the mechanism by which Notch is 
regulated during external sensory organ development (Hutterer and Knoblich 2005). 
Numb plays a role in the internalization of receptors that are involved in cell fate 
decisions during central nervous system development, in neuronal maturation, 
differentiation, and survival. The different human Numb isoforms are suggested to 
play distinct roles in APP metabolism. They also may provide a novel potential link 
between altered Numb isoform expression and increased Aβ generation, the principal 
component of amyloid plaques (Kyriazis, Wei et al. 2008). 
Numb negatively regulates Notch, which is an important player in cellular 
differentiation, proliferation, and apoptotic events, and binds Notch via the PTB-
domain (Guo, Jan et al. 1996). A few years ago it was demonstrated that mammalian 
Numb expression promotes the ubiquitination of membrane-tethered Notch and the 
degradation of the intracellular domain following receptor activation (Guo, Jan et al. 
1996; McGill and McGlade 2003). 
The facts that Numb is closely related to ARH and is involved in endocytosis provides 
two important reasons for considering chicken Numb in the context of studies on 
chicken LDLR family members. 
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Aims of the thesis 
 
 
One aim was to further characterize the protein-protein interaction properties of 
extracellular and intracellular domains of the avian LDLR. The identification of 
binding sites in the ligand binding domain necessary to facilitate binding of human 
apoE to the chicken LDLR was sought. Another aim was to molecularly identify 
chicken Numb and its isoforms and to investigate their binding to cytoplasmic tails of 
receptors of the LDLR family. I analyzed possible differences between the interaction 
of chicken Numb with the human and chicken LDLR. Another aim was to elucidate 
the relationship of chicken LR8 and LR8B in terms of interaction with chicken Numb, 
as the internalization motifs of the cytoplasmic tails of these receptors are identical to 
that of the human LDLR. Finally, since the co-receptor Amnionless contains two 
internalization signals for receptor-mediated endocytosis and its cytoplasmic tail 
interacts with chicken ARH, the aim was to study the binding of the chicken Numb to 
the cytoplasmic domain of chicken Amnionless. 
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Materials and Methods 
 
Animals 
 
Derco-brown laying hens (purchased from Heindl Co. Vienna, Austria), White 
Leghorn laying hens, and the R/O breeding colony, derived from a White Leghorn 
Carrier, were maintained on layer’s mash with free access to water and feed under a 
daily light period of 16 hours. The genotype of the R/O chickens was determined as 
described before (Bujo, Elkin et al. 1996). Animals were sacrified by decapitation. 
Polyclonal antibodies were raised in adult New Zealand White rabbits according to 
standard procedures. All procedures were performed according to the protocols 
approved by the Animal Care Committee of the Medical University of Vienna. 
 
 
Preparation of membrane protein extracts 
 
Freshly obtained tissues were placed in ice-cold buffer A (4ml/g tissue) containing 
20mM Tris/HCl pH 8.0, 1mM CaCl2, 150mM NaCl, and proteinase inhibitor cocktail 
tablets (complete Mini, EDTA free, Roche) and were then homogenized with an Ultra 
Turrax T25 homogenizer 5 times for 30 seconds each. Total homogenates were spun 
for 10min at 3000 x g. The supernatant was filtered through 4 layers of cheesecloth 
(gauze) and was ultracentrifuged at 100000 x g for 1h at 4°C. The resulting 
supernatant was discarded and the centrifugation tube was wiped out to remove 
remaining lipid. The pellet was washed with 3ml buffer A and subsequent 
ultracentrifugation for 1h at 4°C. Then the supernatant was discarded and the pellet 
was solubilized in 1ml buffer B containing 250mM Tris/maleate pH 6.0, 2mM CaCl2 
and proteinase inhibitor cocktail tablets (complete Mini, EDTA free, Roche). 4% of 
the total volume of 4M NaCl was added and the samples were sonicated for 30 sec. 
After adding 10% Triton X-100 to a final concentration of 2%, and ddH2O to a total 
volume of 2ml, the extract was ultracentrifuged for 1h at 100000 x g at 4°C. The 
resulting supernatant was stored at -80°C until use. Protein concentrations were 
determined according to Bradford (Bio-Rad Protein Assay). 
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SDS-PAGE and Western blot analysis 
 
One-dimensional SDS-PAGE (7,5% - 15%) was performed using a minigel system 
(Bio-Rad). Samples were prepared in the presence (reducing conditions) or in the 
absence (non-reducing conditions) of 25mM DTT or beta-Mercaptoethanol. 
Molecular weights were estimated by use of molecular weight markers (Kaleidoscope 
Prestained Standards, Bio-Rad; PageRuler Plus Prestained Protein Ladder, 
Fermentas). The gels were either stained with Coomassie Blue (10% glacial acetic 
acid, 25% isopropanol, 0,278g/l Coomassie Blue R250; GelCode Blue Stain 
Reagent, Pierce) or subjected to Western blot analysis. Proteins were transferred to 
a nitrocellulose-membrane (Hybond-C, Amersham Pharmacia Biotech) by wet 
blotting at 100V. Nonspecific binding sites were blocked with TBS (25mM Tris/HCl 
pH 7.4, 140mM NaCl, and 2,5mM KCl) containing 0,1% Tween-20 and either 5% 
(w/v) non-fat dry milk or 2% BSA (bovine serum albumin) (blocking buffer) for 1h at 
room temperature (RT). Primary antibodies were detected with horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit IgG (1:50000, Sigma) or HRP-
conjugated goat anti-mouse IgG (1:1500, Promega) and enhanced 
chemiluminescence (Pierce). 
 
 
Ligand blotting 
 
For ligand blotting, nitrocellulose strips containing SDS-PAGE separated protein 
extracts were incubated for 1h at RT with TBS (25mM Tris/HCl pH 7.4, 140mM NaCl, 
and 2,5mM KCl) containing 0,1% Tween-20 and either 5% (w/v) nonfat dry milk or 
2% BSA (bovine serum albumin), and 2mM CaCl2 (blocking buffer). The strips were 
then incubated with the indicated ligand at 4°C overnight. Subsequently the strips 
were washed three times for 20min with TBS containing 2mM CaCl2 and 0,1% 
Tween-20 and then incubated with the primary antibodies in blocking buffer for 1h at 
RT. After washing three times for 10min, the bound primary antibody was detected 
with either HRP-conjugated goat anti-rabbit IgG (1:50000, Sigma) or HRP-conjugated 
goat anti-mouse IgG (1:1500, Promega) and enhanced chemiluminescence (Pierce). 
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Table 4. Primers specific for pMAL sequencing. 
Site-directed mutagenesis of the ligand binding domain 
(LA7) of the chicken LDLR 
 
Mutations were introduced by site-directed mutagenesis according to the protocol 
(QuikChange II XL Site-Directed Mutagenesis Kit, Stratagene). 
The pMAL-vector containing the ligand binding domain of the LDLR (Hummel, Lynn 
et al. 2003) was used as template for the site-directed mutagenesis. 
Mutagenesis was performed with the following mutagenic sense and antisense 
primer (table 3): 
 
sense 5’- GAC GGC AGC GAT GAG TCG CCC GAA ATG TGC CGC GG-3’ 
LA7m 
antisense 5’- GCG GCA CAT TTC GGG CGA CTC ATC GCT GCC GTC GG-3’ 
sense 5’-GAT GGG TCC GAC GAG GAA GGA TGC GAC CCC CCC-3’ 
LA7m5 
antisense 5’-GGG GGG GTC GCA TCC TTC CTC GTC GGA CCC ATC-3’ 
sense 
5’-GAA CGG AGC CCG ACG TGC ∆ GGG GTC GTC CCC CGG 
CCC-3’ 
LA7∆ 
antisense 
5’-GGG CCG GGG GAC GAC CCC ∆ GCA CGT CGG GCT CCG 
TTC-3’ 
sense 5’-GAT GGG TCC GAC GAG GAA GGA TGC GAC CCC CCC-3’  
LA7dbl 
antisense 5’-GGG GGG GTC GCA TCC TTC CTC GTC GGA CCC ATC-3’ 
 
 
 
 
For the LA7 double mutant (LA7dbl) the LA7m plasmid DNA was applied as a 
template and the LA7m5 primers were used for introducing the second mutation. The 
constructs were verified by sequencing using pMAL-seq forward and reverse primer 
(table 4), primers specific for the pMAL-vector. 
  
pMAL-seq forward 5’-AAC CTC GGG ATC GAG GG-3’ 
pMAL-seq reverse 5’-CCA GTG CCA AGC TTG GTA CC-3’ 
 
 
 
 
 
Table 3. Primers used for the site-directed mutagenesis of ggLA7. 
Letters or symbols in green indicate the site of mutations. 
Materials and Methods 
- 49 - 
Expression, purification, and refolding of ggLA7 wild type 
and ggLA7 mutants 
 
The expression was carried out as previously described (Bajari, Strasser et al. 2005), 
besides that the induction was done at an OD600 of 0.6 and at 37°C. The recombinant 
His fusion proteins were purified by Ni-NTA affinity chromatography according to the 
manufacturer’s instructions (Qiagen). For refolding of the recombinant proteins, 
purified HisRAPmyc was coupled to CNBr-activated Sepharose (Amersham-
Pharmacia Biotech) according to the manufacturer’s protocol. The proteins were 
refolded as described before (Bajari, Strasser et al. 2005). 
 
 
Co-Immunoprecipitation 
 
The receptor was incubated with the ligand for 2h at room temperature on an 
overhead shaker. After this incubation step the appropriate antibody was added and 
incubated at 4°C for 2h on an overhead shaker. After that 50µl of Protein A 
Sepharose were added and rotated over night at 4°C. The beads were washed four 
times with 1xTBST + 2mM CaCl2 supplied with protease inhibitors with centrifugation 
steps at 370 x g for 2min at 4°C in-between. After the final centrifugation step 70µl 
reducing Laemmli buffer were added and the mixture was heated for 10min at 95°C. 
Then the samples were applied to SDS-PAGE and analyzed by Western blotting. 
 
 
Antibodies 
 
Murine monoclonal Penta-His antibody (Qiagen; used at 1:2000), mouse anti-
glutathione S-transferase (GST) antibody (BD Pharming; used at 1:2000), mouse 
anti-maltose-binding-protein (MBP) antibody (New England Biolabs; used at 
1:30000), mouse anti-HSV antibody (Novagen; used at 1:20000) and mouse anti-
human ApoE (Sigma; used at 1:5000) were purchased from the indicated source. 
Mouse anti-c-myc was secreted of the hybridoma cell line clone 9E10 (ATCC; used 
1:100). The hybridoma cell line was purchased from the indicated source. Rabbit 
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anti-ggLR8 IgG (used at 2µg/µl) was prepared as described previously (Bujo, 
Yamamoto et al. 1995). Polyclonal Antibody against the chicken LA domain (anti-
LA1-7; used at 1:1000) was prepared as described before (Hummel, Lynn et al. 
2003). The antiserum against chicken Numb (anti-Numb; used at 1:500), against a 
peptide representing the C-terminal 20 aa, was prepared as described previously 
(Dichlberger 2004). The human ARH antibody (#65; used at 1:500), against a peptide 
corresponding to the amino acids 89-117, was prepared as described elsewhere 
(Grünstäudl 2005). Anti-rabbit HRP (horseradish peroxidase)-conjugated antibodies 
(Sigma; used at 1:50000), and anti-mouse HRP-conjugated antibodies (Promega; 
used at 1:1500) were purchased from the indicated source. 
 
 
Cell culture and ApoE preparation 
 
Chinese hamster ovary (CHO) cells secreting human apoE2, apoE3, and apoE4 
isoforms characterized in (Stannard, Riddell et al. 2001; Sacre, Stannard et al. 2003) 
were used as source of human apoE-containing lipoprotein particles. ApoE-secreting 
cells and control CHO cells were cultured in 100 mm dishes with Iscove’s MEM 
supplemented with 5% FCS, 1% non essential amino acids, 1% glutamine, and 1% 
penicillin/streptomycin. Before harvesting the apoE isoforms, cells were cultured in 
150 mm dishes. At a confluence of 80% the growth medium was switched to 
harvesting media (OptiMEM, Invitrogen). The isoform conditioned media were 
collected 3-4 times after 12 h conditioning period and concentrated using Amicon-
Ultra concentration columns with a 30 MWCO (molecular weight cut off). ApoE 
isoform levels were quantified by ELISA (ApoE/Pan-ApoE ELISA kit, MBL). 
DKO-R cells were maintained as described in Wettey et al (Wettey, Hawkins et al. 
2002). The cells were harvested, if they were 80% confluent. 
 
 
Cloning of chicken Numb isoforms 
 
cDNA was generated by reverse-transcriptase PCR (Superscript II, Invitrogen) using 
total RNA (Nucleo Spin, Macherey&Nagel) of different tissues of laying hens. 
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Sequence-specific primers for RT-PCR were designed using the potential chicken 
Numb sequence from the NCBI (www.ncbi.nlm.nih.gov) and Ensembl 
(www.ensembl.org) databases. PCR of full-length chicken Numb was performed 
using the forward primer including an EcoRI restriction site (bold) 5’-
AAGAATTCCATGAATAAATTACGGCAG-3’ corresponding to nucleotides 1 to 18  of 
the NCBI sequence and the reverse primer including a XhoI restriction site (bold) 5’-
GTCTCGAGAAGTTCAATCTCAAATGTC-3’ corresponding to nucleotides 1728 to 
1746. The PCR product was T/A cloned into the pCR2.1 vector (Invitrogen) and 
confirmed by DNA sequencing using the standard sequencing primer M13 forward 
and M13 reverse. 
 
 
Prokaryotic expression of recombinant His-tagged chicken 
Numb isoforms 
 
The insert of the clone with the right sequence (see above) was cut out and directly 
cloned in-frame into the pET-25b+-expression vector (Novagen) providing a C-
terminal HSV- and His-tag. Recombinant ggNumb-His was expressed in E. coli BL21 
Star chemically competent cells (Invitrogen). Expression was performed according to 
the protocol from Qiagen. 
 
 
Cloning of the chicken Numb PRR insert and prokaryotic 
expression  
 
The cloning procedure was carried out as for the chicken Numb isoforms and also 
the prokaryotic expression. 
Unless for full-length PRRi RT-PCR the following primers were used, the forward 
primer including an EcoRI restriction site (bold) 5’-
CAGAATTCCGTTAATGGCACTGCC-3’ and the reverse primer containing a XhoI 
restriction site (bold) 5’-GTCTCGAGGCCAGAGACCATGGC-3’. 
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GST-tagged fusion proteins 
 
For my studies, I used four different cytoplasmic tails (ct), these are: chicken LDLR 
ct, human LDLR ct, chicken LR8 ct, and chicken LR8B ct. The cloning, expression, 
and purification of GST-His-ggLDLRct and GST-humanLDLRct-myc were described 
in (Grünstäudl 2005). The design of GST-ggLR8ct-myc and GST-ggLR8Bct-myc 
were described in (Gschmeidler 2004). 
The full-length ARH was cloned into pGEX-5X-1 vector (Amersham Biosciences) to 
generate a GST-tagged fusion protein. The cloning, expression, and purification of 
GST-ARH were described in (Grünstäudl 2005). 
 
 
His-tagged fusion proteins 
 
His-tagged chicken Amnionless cytoplasmic tail (ggAmnionless ct-His) was cloned, 
expressed, and purified as described in (Christian 2006). 
The expression of His- and myc-tagged RAP was performed as depicted in (Bajari, 
Strasser et al. 2005). 
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Results 
 
LDL receptor in human and chicken 
 
The LDLR (Brown and Goldstein 1974; Goldstein and Brown 1974; Brown and 
Goldstein 1986) is an important component in the feed-back maintenance of 
cholesterol homeostasis, a well-understood mechanism in mammals. Following 
LDLR-mediated endocytosis, LDL-derived cholesterol and its intracellularly 
generated oxidated derivatives mediate a complex series of feedback mechanisms to 
protect the cell from overaccumulation of cholesterol. 
The first avian LDLR was identified only in 2003 (Hummel, Lynn et al. 2003). Likely 
reasons for the long-term failure to identify and characterize LDLRs in egg-laying 
species are their low expression levels and modest sterol-mediated regulation 
compared to their mammalian relatives. The chicken LDLR cDNA (NCBI; AJ 515243) 
displays an open reading frame of 2676bp, and the gene’s chromosomal location has 
not been established yet. 
The structure of the novel protein entirely conforms to that of the mammalian LDLR 
(see Fig. 22). Besides containing all of the common structural elements of the 
lipoprotein receptor family, the hallmarks of the LDLR are i) a ligand binding domain 
consisting of seven LA repeats, where the first four are separated from repeats five 
through seven by a linker of variable length; ii) the EGF precursor homology domain; 
iii) an O-linked sugar domain; iv) a membrane anchoring domain and v) a short 
cytoplasmic tail containing an internalization signal, which is important for endocytic 
activity. 
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Figure 22. Sequence comparison of chicken LDLR and human LDLR. 
Numbering of the amino acid sequences starts at the methionine residue corresponding to 
the initiation codon. Gaps (-) have been introduced to optimize the alignment. 
1-7 are the seven ligand binding (LA) repeats; the EGF repeats A, B, and C are in green; 
the O-linked sugar domain is underlined; the transmembrane domain is indicated by a 
dashed line; the internalization signal is indicated by a dotted underline; the six “YWTD” 
tetrapeptides (Jeon, Meng et al. 2001) are marked with asterisks. The red arrow shows the 
signal peptide cleavage site. 
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The chicken LDLR appears to interact prefentially with chicken LDL, and less with 
chicken VLDL. This is significant, since avian LDL and VLDL particles differ in lipid 
composition. Furthermore, chicken LDL and VLDL contain only the apoB100 isoform 
of apoB and lack apoE, which is not expressed in birds. 
 
 
Characterization of the chicken LDLR ligand binding 
domain 
 
Site-directed mutagenesis of the ligand binding domain 
 
The human LDLR and the chicken LR8 (Steyrer, Barber et al. 1990) both bind apoE, 
i.e. apoE3 and apoE4 with high affinity and apoE2 with much reduced affinity. Due to 
the fact that the human LDLR and the ggLR8 bind apoE (Fig. 24), but the ggLDLR 
does not, one aim of my thesis was to mutate the ggLDLR ligand binding domain at 
specific positions, which are known to be important for apoE binding in mammalian 
receptors. The objective was to determine the sites, which are crucial for binding of 
apoE to the LDLR and to exploit the avian system to better understand the interaction 
of apoE with the LDLR at the molecular level. 
The specific mutations shown in Fig. 23 were introduced with site-directed 
mutagenesis as described in Materials and Methods, in an attempt to change the 
chicken receptor’s ligand binding domain more like that of the human protein and 
thereby to gain insight into the overall structure of the ligand binding domain and the 
details of its interaction with apoE. 
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As a template for the site-directed mutagenesis the LA7wt (wild type, without 
mutations) plasmid as described in Hummel et al (Hummel, Lynn et al. 2003) was 
used. 
 
In order to confirm that LR8 binds to apoE for control purposes, membrane proteins 
of chicken ovarian follicles, which are enriched in LR8, were electrophoretically 
separated under non-reducing conditions (Fig. 24, lanes 1-5), blotted onto 
nitrocellulose membrane and incubated with apoE2 (Fig. 24, lane 3), apoE3 (Fig. 24, 
lane 4), and apoE4 (Fig. 24, lane 5). The apoE isoforms were produced in and 
secreted from CHO cells (see Materials and Methods). Medium from control CHO 
cells, not secreting apoE isoforms, was used for incubations not containing the ligand 
(Fig. 24, lane 2). 
 
 
 
Figure 23. The specific mutations in the chicken LDLR ligand binding domain (LA 1-7). 
In the LA7m mutant the sequence SDEE in the first LA repeat were mutated into SDES. In the 
LA7∆, the long A/E-rich linker between repeats 4 and 5 was deleted. The LA7m5 mutant was 
generated by substitution of aa SDED with SDEE in the fifth repeat. In the LA7dbl double 
mutant the mutations LA7m and LA7m5 were introduced together. 
The red arrow indicates the signal peptide cleavage site. 
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The position of the bound ligand was visualized by immunoblotting with anti-human 
ApoE antibody (Fig. 24, lanes 3-5). The apoE isoforms clearly bound to LR8, a 95 
kDa protein in the ovarian follicle membrane extract, which was visualized with anti-
ggLR8 antiserum (Fig. 24, lane 1). The binding of apoE2 (Fig. 24, lane 3) is weaker 
than that of apoE3 (Fig. 24, lane 4) and apoE4 (Fig. 24, lane 5) in agreement with a 
previous publication from our group (Steyrer, Barber et al. 1990). Incubation with 
control medium of the CHO cells, i.e. without apoE, gave no signal (Fig. 24, lane 2). 
 
 
Expression, purification, and refolding of the LDLR ligand binding 
domains 
 
The wt and mutated LA7 (Fig. 25) were expressed in BL21 Escherichia coli cells as 
fusion proteins with maltose-binding protein (MBP), purified, and refolded as 
described in Materials and Methods. 
 
 
 
 
Figure 25. Scheme of the MBP•chicken LA7•6xHis recombinant fusion protein. 
The wt and mutated LA7 domains, lacking the N-terminal signal peptide, were cloned into the pMAL 
vector, providing an N-terminal maltose-binding protein and a C-terminal His-tag. 
Figure 24. Human apoE binds to the 
chicken VLDLR homolog LR8. 
Nitrocellulose strips containing proteins 
from ovarian follicle membrane extracts 
(25µg each), separated by 12% SDS-
PAGE under non-reducing (lanes 1-5) 
conditions, were incubated with control 
medium of CHO cells (lane 2), apoE2 
(1µg, lane 3), apoE3 (1µg, lane 4), and 
apoE4 (1µg, lane 5). The strips were 
washed and incubated with anti-human 
ApoE antibody (lanes 2-5). LR8, 
enriched in the ovarian follicle 
membrane protein extract, was 
visualized by Western blotting with 
anti-ggLR8 antiserum (lane 1). The 
primary antibodies were detected with 
HRP-conjugated goat anti-rabbit IgG 
(1:50000, lane 1) or HRP-conjugated 
goat anti-mouse IgG (1:1500, lanes 2-
5) and enhanced chemiluminescence. 
The positions of migration (kDa) of 
marker proteins are indicated. 
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After refolding, the different LA7 proteins were applied to SDS-PAGE under reducing 
(reverting to the unfolded form of the domains) and non-reducing conditions and 
subsequently analyzed with Coomassie Blue stain (Fig. 26) and Western blotting 
using an anti-His antibody (Fig. 27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. SDS-PAGE/ 
Coomassie Blue stain of the 
folded and unfolded 
MBP•LA7•His fusion proteins. 
2µg each of the proteins were 
subjected to SDS-PAGE under 
reducing (R), by adding 25mM 
DTT, and under non-reducing (NR) 
conditions and analyzed by 
Coomassie Blue stain. The LA7m5 
is marked with brown arrows, as it 
shows weak staining. 
The positions of migration (kDa) of 
marker proteins are indicated. 
Figure 27.  Western blot analysis 
of the folded and unfolded 
MBP•LA7•His fusion proteins. 
2µg each of the proteins shown in 
Fig. 26 were subjected to SDS-
PAGE under reducing (25mM 
DTT) and under non-reducing 
conditions, and analyzed by 
Western blotting using an anti-His 
antibody. The bound primary 
antibodies were detected with 
HRP-conjugated goat anti-mouse 
IgG (1:1500) and enhanced 
chemiluminescence. 
The positions of migration (kDa) of 
marker proteins are indicated. 
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Figure 28. LA7 wt and mutants bind to the recombinant His•RAP•myc fusion protein. 
20µg of LA7 proteins (lanes 1-5) were preincubated with 15µg of RAP and then mixed with anti-myc 
antibody. Subsequently, Protein A Sepharose was added. After the co-immunoprecipitation the 
samples were separated by 7,5% SDS-PAGE under reducing conditions. The nitrocellulose 
membrane was then incubated with anti-LA1-7 antiserum. In lane 6 the LA7 domain, in this case 
LA7dbl, was visualized. The primary antibody was detected with HRP-conjugated goat anti-rabbit 
IgG (1:50000, lanes 1-6) and enhanced chemiluminescence. The positions of migration (kDa) of 
marker proteins are indicated. 
The reducing conditions unfold the receptor ligand binding domains, and therefore 
the proteins have reduced electrophoretic mobility. 
 
 
Analysis of the ligand binding ability of the recombinant LA7 fusion 
proteins 
 
RAP, receptor-associated protein, is an endoplasmic reticulum (ER) - resident 
chaperone that is required for maturation of members of the LDLR family. It is known 
that RAP binds to all LDLR family member proteins and can antagonize the binding 
of a wide variety of ligands (Herz, Goldstein et al. 1991; Willnow, Rohlmann et al. 
1996). Therefore, RAP was used as a positive control to test the binding ability of the 
refolded receptor binding domains. The LA7 proteins were incubated with the 
recombinant RAP and co-immunoprecipitated with His-RAP-myc (Koch, Strasser et 
al. 2002) using the anti-myc antibody, and then analyzed on Western blots using anti-
LA1-7 antibody as the primary antibody (see Fig. 28). 
 
 
 
 
 
 
 
 
 
 
 
 
The LA7wt, LA7m, LA7∆, LA7dbl, and LA7m5 were incubated with His-RAP-myc and 
precipitated with anti-myc antibody. The samples were subjected to SDS-PAGE and 
analyzed by Western blot using anti-LA1-7 antiserum (Fig. 28, lanes 1-5). The 
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position of the LA7 binding domain was visualized with anti-LA1-7 antiserum (Fig. 28, 
lane 6). 
The co-immunoprecipitation (Fig. 28) demonstrated that the receptor ligand binding 
domain is able to bind the His-RAP-myc protein, except LA7m5. LA7m5 does not 
appear to bind RAP, which could be due to the fact that the expression of LA7m5 
protein did not work well (cf. Fig. 26 and 27) and therefore less protein was available 
than in the other mutants. 
If the immunoprecipitation was performed in the absence of His-RAP-myc, i.e. LA7 
domains were incubated with anti-myc antibody and Protein A Sepharose alone, no 
signal could be obtained on the Western blot (data not shown). 
 
 
Characterization of the protein interaction properties of the 
intracellular binding domain of LDLR family members 
 
Interaction of adaptor proteins with the cytoplasmic tail of the LDLR 
 
It is known that the adaptor protein ARH interacts with the FxNPxY motif in the 
cytoplasmic tails of the LDLR family members (Mishra, Watkins et al. 2002). ARH is 
required for the efficient internalization of the LDL-LDLR complex (Eden, Patel et al. 
2002). It has been shown in our laboratory previously that the human ARH also binds 
to the chicken LDLR cytoplasmic tail (ggLDLRct), but to a lesser extent than to that of 
the human receptor. In turn, chicken ARH, cloned in our laboratory, binds to both the 
ggLDLRct and human LDLR cytoplasmic tail (hLDLRct), but the heterologous 
interaction displays much lower affinity (Grünstäudl 2005). Furthermore it has been 
observed that chicken ARH interacts with the chicken LR8B’s cytoplasmic tail 
(ggLR8Bct), but not with the chicken LR8’s cytoplasmic tail (ggLR8ct) although they 
possess the same internalization signal, FDNPVY (Gschmeidler 2004). Due to the 
fact that Numb is closely related to ARH (Mishra, Watkins et al. 2002) and is involved 
in endocytosis (Santolini, Puri et al. 2000; Berdnik, Torok et al. 2002), I considered 
investigating chicken Numb in the context of chicken LDLR family members. 
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Figure 29. Genomic organization of chicken Numb. 
The chicken Numb gene locus can be found on chicken chromosome 5 (lavender box in the 
upper panel). The gene contains 12 exons, which are depicted as boxes in the lower panel. 
The 5’ untranslated region (5’ UTR) is shown as brown boxes. The start and stop codon 
(yellow boxes) are marked with arrowheads. The 5 ’upstream and 3’ downstream 
sequences are shown in black. The introns are represented as blue lines. 
Chicken Numb  
 
Genomic organization of chicken Numb according to the Ensembl chicken database 
 
Concerning the genomic organization of chicken Numb, searches in the Ensembl 
chicken database revealed its location on chicken chromosome 5. The Numb gene 
spans an 92,8 kb stretch on chromosome 5 from basepairs 28,378,441 to 28,471,234 
(ENSGALT00000015137). The predicted chicken Numb transcript is 2,245bp long 
and contains 12 exons (Fig. 29). Exon 1, exon 2, exon 3, and the 5’ part of exon 4 
contain a 5’ untranslated region (5’ UTR). The actual protein is encoded by the 
region, which spans from the 3’ part of exon 4 to exon 12 (Fig. 29). 
 
 
Chicken Numb protein 
 
The chicken Numb protein consists of 585 amino acids and has a calculated 
(PROTEIN CALCULATOR v3.3) molecular mass of approximately 64kDa. Chicken 
Numb displays about 83% sequence identity to human and murine Numb (Fig. 30), 
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whereas human and murine Numb share 94% sequence identity (Fig. 30). Hence, 
Numb appears to be an evolutionarily well conserved protein. 
 
 
 
 
 
Wakamatsu et al (Wakamatsu, Maynard et al. 1999) have reported the detection of 
an approximately 80 kDa band in chicken E3 neuronal tube extract by 
immunoblotting (Wakamatsu, Maynard et al. 1999). They showed that ggNumb can 
modulate neurogenesis by binding directly to the cytoplasmic domain of the activated 
form of ggNotch-1. 
The protein sequences from the Ensembl database and that published by 
Wakamatsu et al differ in a few positions, as can be seen in Fig. 31. 
 
Figure 30. Protein sequence alignment of Numb from chicken, mouse, and man. 
The chicken Numb sequence originates from the Ensembl database (NP_990166.1). 
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According to computational sequence analysis the chicken Numb protein contains 
three potential N-glycosylation motifs (NxS/T) at aa positions 361, 527, and 566 (Fig. 
32). 
 
 
 
Recently, in our laboratory an antibody against chicken Numb was raised. The 
peptide antibody was generated against a peptide corresponding to the C-terminal 20 
amino acids of the chicken Numb (shown in Fig. 32). 
Figure 32. Chicken Numb protein sequence. 
The predicted putative N-glycosylation sites are encircled in green. The 20 aa peptide 
synthesized for the generation of a peptide antibody is enboxed in red. 
Figure 31. Alignment of the Ensembl ggNumb sequence (ensembl) and that published 
by Wakamatsu et al. (wakamatsu). 
Differences in the sequences are enboxed in red. 
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Chicken Numb isoforms 
 
In mammals, four different isoforms of Numb are known. Sequence alignments of 
chicken Numb with human and murine Numb have shown a high homology and 
sequence conservation. Through nucleotide-nucleotide and protein-protein BLAST 
analysis of the specific phosphotyrosine-binding domain insert (PTBi) and proline-rich 
region insert (PRRi) of the human Numb against the chicken genome, different 
chicken Numb isoforms have been revealed (Dichlberger 2004). These potential 
chicken Numb sequences differ in the presence or absence of inserts in the 
phosphotyrosine-binding domain (PTB) and the proline-rich region (PRR), 
respectively (Fig. 33). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sequence analysis of the chicken gene locus showed that the hypothetical PTB- and 
PRR-encoding inserts are located in different introns. The potential chicken Numb 
PTBi contains 11 aa which are 100% conserved in mammals and the inserted 
basepairs can be found in the intron 5-6 (between exons 5 and 6), from bp 
Figure 33. Genomic locations of the PTB and PRR inserts of chicken Numb. 
The corresponding flanking exons are shown as yellow arrow bars. Exon-intron 
boundaries are indicated with black arrow heads. A) The location of the PTBi is 
shown as a green box. B) The PRRi is depicted as a blue box. 
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28,447,302 to 28,460,389, which is 13,088 bp long (Fig. 33, A). The PRRi is 48 aa 
long and the encoding insert is located in the intron10-11 (between exons 10 and 
11), which is 2,242 bp long and stretches from bp 28,468,277 to 28,470,518 (Fig. 33, 
B). The PRRi shares about 56% sequence identity with the mammalian PRR inserts. 
 
 
Cloning of the chicken Numb isoform1 
 
Total RNA was isolated from DKO-R cells and RT-PCR was performed using the 
sequence-specific forward primer, 5’-AAGAATTCCATGAATAAATTACGGCAG-3’ 
(containing an EcoRI site, underlined), and the reverse primer 5’-
GTCTCGAGAAGTTCAATCTCAAATGTC-3’ (containing an XhoI site, underlined). 
DKO-R cells are DT40 cells, which express the human clathrin cDNA under the 
control of a Tet-Off expression system. The DT40 cell line is a chicken B cell line and 
a popular tool for gene targeting in vertebrate cells (Buerstedde and Takeda 1991; 
Winding and Berchtold 2001). 
DKO-R cells remain viable in the absence of clathrin (Wettey, Hawkins et al. 2002). 
The sequence of ggNumb was verified by DNA sequencing, but it differs from both 
the Ensembl sequence and the sequence published by Wakamatsu et al (Fig. 34); in 
the following, this sequence was designated chicken/ggNumb isoform1. 
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Bacterial expression of recombinant chicken Numb isoform1 
 
The pET25b+-vector expression system was used to bacterially produce His6-tagged 
ggNumb isoform1. 
 
 
 
 
 
 
Figure 34. Protein sequence alignment of ggNumb-isoform1, ensembl-ggNumb, and 
wakamatsu-ggNumb. 
Differences in the sequences are highlighted in orange. 
Figure 35. Schematic representation of the recombinant chicken Numb-
isoform1•HSV•6xHis fusion protein. 
Full-length ggNumb isoform1 (shown as a yellow bar) was cloned into the pET25b+-
expression vector, which carries an optional C-terminal HSV•Tag (blue box) and a 6xHis•Tag 
(red box) sequence. 
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The full-length ggNumb cDNA fragment was cloned between the EcoRI and XhoI 
sites into the pET25b+-vector providing a C-terminal HSV-Tag and a 6xHis-Tag (Fig. 
35). The construct was verified by DNA sequencing. The recombinant chicken Numb-
isoform1•HSV•6xHis fusion protein was bacterially expressed in BL21 cells. The 
induction of protein expression of the approximately 80 kDa ggNumb-iso1-His fusion 
protein is shown in Fig. 36 A. and B. The His-tagged ggNumb-iso1 was subsequently 
used for studies on binding of Numb to cytoplasmic tails of various members of the 
LDLR family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cloning of the chicken Numb isoform2 
 
Different chicken tissues were screened for the insert in the PTB domain with the 
PTBi-specific forward primer 5’-ATGAATAAATTACGGCAGAGC-3’ and reverse 
primer 5’-AGCCTTTGAAGAACTTCC-3’. Based on the results, I concentrated on 
chicken embryo cDNA and performed full-length RT-PCR with sequence-specific 
primers (mentioned above) containing the EcoRI and XhoI restriction sites. The 
sequence was verified by DNA sequencing. The alignment of chicken Numb isoform1 
and 2 (Fig. 37) shows that the PTB insert is present in the isoform2. Additionally, an 
Figure 36. Bacterial expression of ggNumb-isoform1•His fusion protein. 
The recombinant ggNumb isoform1 fusion protein was expressed in BL21 cells. 
Cell extracts, before (lane 1) and after (lane 2) 3 h of induction with 1mM IPTG, 
were subjected to SDS-PAGE under reducing conditions and analyzed by 
Western blotting using anti-ggNumb antiserum (A.) and anti-His antibody (B.). 
The bound primary antibodies were detected with HRP-conjugated goat anti-
rabbit IgG (1:50000, A.), HRP-conjugated goat anti-mouse IgG (1:1500, B.), and 
enhanced chemiluminescence. The positions of migration (kDa) of marker 
proteins are indicated. 
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in-frame insert immediately before the canonical PTB inserted sequence was present 
in the chicken isoform2. The methionine in this insert is an isoleucine in the Ensembl 
database. 
 
 
 
 
 
Bacterial expression of recombinant chicken Numb isoform2 
 
For the bacterial production of His6-tagged ggNumb isoform2 the pET25b+-vector 
expression system was used. 
 
 
 
 
 
 
 
Figure 37. Protein sequence alignment of chicken Numb-isoform1 and -isoform2. 
The PTBi domain also found in mammalian Numb is enboxed in green. The blue frame 
shows the additional sequence present in the chicken protein. 
Figure 38. Schematic drawing of the recombinant chicken Numb-isoform2•HSV•6xHis 
fusion protein containing the insert in the PTB domain. 
Full-length ggNumb isoform2 (shown as a yellow bar) was cloned into the pET25b+-
expression vector, which carries an optional C-terminal HSV•Tag (blue box) and a 6xHis•Tag 
(red box) sequence. The insert in the PTB domain (PTBi) is represented as a green box. 
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The full-length ggNumb cDNA fragment was cloned into the pET25b+-vector 
providing a C-terminal HSV-Tag and a 6xHis-Tag (Fig. 38). The construct was 
verified by DNA sequencing. The recombinant chicken Numb-isoform2•HSV•6xHis 
fusion protein was bacterially expressed in BL21 cells. The induction of protein 
expression of the approximately 90 kDa ggNumb-iso2-His fusion protein is shown in 
Fig. 39 A., B., and C. The His-tagged ggNumb-iso2 was subsequently used for 
binding studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cloning of the chicken Numb isoform3 
 
Different chicken tissues were screened for the insert in the PRR domain with PRRi 
specific primers, forward: 5’-ATCACCAGTGCGTTCAGCACG-3’; reverse: 5’-
GCTGGCTGCTGCTGCTGCT-3’. Based on the results, I focused on the chicken 
kidney, and full-length RT-PCR with sequence-specific primers (see above), was 
performed. The sequence was verified by DNA sequencing. The protein sequence 
Figure 39. Bacterial expression of ggNumb-
isoform2•His fusion protein. 
The recombinant ggNumb isoform2 fusion protein 
was expressed in BL21 cells. Cell extracts, 
before (lane 1) and after (lane 2) 3 h of induction 
with 1mM IPTG, were subjected to SDS-PAGE 
under reducing conditions and subsequently 
analyzed by Coomassie Blue stain (A.) and 
Western blotting using anti-ggNumb antiserum 
(B.) and anti-His antibody (C.). The bound 
primary antibodies were detected with HRP-
conjugated goat anti-rabbit IgG (1:50000, B.), 
HRP-conjugated goat anti-mouse IgG (1:1500, 
C.) and enhanced chemiluminescence. The 
positions of migration (kDa) of marker proteins 
are indicated. 
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alignment of chicken Numb isoforms1 and 3 is shown in Fig. 40. The PRR insert 
(enboxed in green) is present in the isoform3. 
 
 
 
 
Bacterial expression of recombinant chicken Numb isoform3 
 
The pET25b+-vector expression system was used to bacterially produce His6-tagged 
ggNumb isoform3. 
 
 
 
 
 
 
Figure 40. Alignment of the chicken Numb-isoform1 and -isoform3. 
Differences in the sequences are shown in orange. The PRRi is enboxed in green. 
Figure 41. Schematic representation of the recombinant chicken Numb-
isoform3•HSV•6xHis fusion protein containing the insert in the PRR domain. 
Full-length ggNumb isoform3 (shown as a yellow bar) was cloned into the pET25b+-
expression vector, which carries an optional C-terminal HSV•Tag (blue box) and a 6xHis•Tag 
(red box) sequence. The PRRi is shown as a green box. 
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The full-length ggNumb cDNA fragment was cloned between the EcoRI and XhoI 
sites into the pET25b+-vector providing a C-terminal HSV-Tag and a 6xHis-Tag (Fig. 
41). The construct was verified by DNA sequencing. The recombinant chicken Numb-
isoform3•HSV•6xHis fusion protein was bacterially expressed in BL21 cells. The 
induction of protein expression of the approximately 95 kDa ggNumb-iso3-His fusion 
protein is shown in Fig. 42 A. to C. The His-tagged ggNumb-iso3 was also 
subsequently used for studies on binding of Numb to cytoplasmic tails of various 
members of the LDLR family and to investigate whether the PRR insert makes a 
difference in binding ability, in contrast to isoform1 and 2. 
 
 
 
 
 
 
 
 
 
 
 
Binding of chicken Numb isoforms to the cytoplasmic tails of chicken and 
human LDLR 
 
It has been shown that the PTB domain of ARH binds to the cytoplasmic domain of 
the human LDLR, and that this binding requires the integrity of the FDNPVY 
sequence (He, Gupta et al. 2002). Instead of FDNPVY, the chicken LDLR harbors  
Figure 42. Bacterial expression of ggNumb-isoform3•His 
fusion protein. 
The recombinant ggNumb isoform3 fusion protein was 
expressed in BL21 cells. Cell extracts, before (lane 1) and 
after (lane 2) 3 h of induction with 1mM IPTG, were subjected 
to SDS-PAGE under reducing conditions and subsequently 
analyzed by Coomassie Blue stain (A.) and Western blotting 
using anti-ggNumb antiserum (B.) and anti-His antibody (C.). 
The bound primary antibodies were detected with HRP-
conjugated goat anti-rabbit IgG (1:50000, B.), HRP-
conjugated goat anti-mouse IgG (1:1500, C.) and enhanced 
chemiluminescence. The positions of migration (kDa) of 
marker proteins are indicated. 
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the supposed internalization signal FGNPLF (Hummel, Lynn et al. 2003). 
The aim was to investigate whether the different chicken Numb isoforms are able to 
interact with the human or chicken intracellular domain of the LDLR, based on the 
fact that the Numb PTB is related to that of ARH. 
For this purpose the ligand blotting method, as described in Materials and Methods, 
was used. 
First, the interaction of chicken Numb isoforms with the human LDLRct was tested 
(see Fig. 43 A. and B.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43. Human LDLRct fusion protein binds to the chicken Numb isoform3. 
Nitrocellulose strips containing GST-humanLDLRct-myc (A. and B. lane 1: 0,5µg; lanes 2-
3b: 1µg), separated by 12% SDS-PAGE under non-reducing conditions, were incubated 
with ggNumb-iso1-His crude extract (600µg, A. lane 2), ggNumb-iso3-His crude extract 
(600µg, A. lanes 3a and 3b), and ggNumb-iso2-His crude extract (600µg, B. lanes 2 and 3). 
The strips were washed and incubated with anti-ggNumb antiserum (A. lanes 2-3b; B. lane 
2) and anti-His antibody (B. lane 3), respectively. GST-humanLDLRct-myc was visualized by 
Western blotting by using anti-GST antibody (A. and B. lane 1). The primary antibodies were 
detected with HRP-conjugated goat anti-rabbit IgG (1:50000, A. lanes 2-3b; B. lane 2) or 
HRP-conjugated goat anti-mouse IgG (1:1500, A. and B. lane 1; B. lane 3) and enhanced 
chemiluminescence. The difference between A. lane 3a and 3b is a longer exposure time in 
lane 3b.The positions of migration (kDa) of marker proteins are indicated. 
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The position of the bound ligands was visualized by immunoblotting with anti-
ggNumb antiserum (Fig. 43, A. lanes 2-3b; B. lane 2) and anti-His antibody (Fig. 43, 
B. lane 3), respectively. Chicken Numb isoform3 clearly bound to the approximately 
35kDa human LDLRct (Fig. 43, A. lane 3b). The position of the cytoplasmic tail was 
immunologically shown by using anti-GST antibody (Fig. 43, A. and B., lane 1). No 
signals could be obtained, when chicken Numb isoform1 (Fig. 43, A. lane 2) or 
chicken Numb isoform2 (Fig. 43, B. lanes 2 and 3) were used as a ligand. 
In the following experiments the chicken LDLRct was tested for interaction with 
chicken Numb isoforms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 44. Chicken LDLRct fusion protein binds to the chicken Numb isoform3. 
Nitrocellulose strips containing GST-His-ggLDLRct (A. and B. lane 1: 0,5µg; lanes 2-3b: 
1µg), separated by 12% SDS-PAGE under non-reducing conditions, were incubated with 
ggNumb-iso1-His crude extract (600µg, A. lane 2), ggNumb-iso3-His crude extract (600µg, 
A. lanes 3a and 3b), and ggNumb-iso2-His crude extract (600µg, B. lanes 2 and 3) . The 
strips were washed and incubated with anti-ggNumb antiserum (A. lanes 2-3b; B. lane 2) 
and anti-HSV antibody (B. lane 3). GST-His-ggLDLRct was visualized by Western blotting 
by using anti-GST antibody (A. and B. lane 1). The primary antibodies were detected with 
HRP-conjugated goat anti-rabbit IgG (1:50000, A. lanes 2-3b; B. lane 2) or HRP-
conjugated goat anti-mouse IgG (1:1500, A. lane 1; B. lanes 1 and 3) and enhanced 
chemiluminescence. The difference between A. lane 3a and 3b is a longer exposure time 
in lane 3b.The positions of migration (kDa) of marker proteins are indicated. 
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The approximately 30kDa chicken LDLRct was visualized with anti-GST antibody 
(Fig. 44, A. and B. lane 1). The bound ligands were detected with anti-ggNumb 
antiserum (Fig. 44, A. lanes 2-3b; B. lane 2) and anti-HSV antibody (Fig. 44, B. lane 
3). Chicken Numb isoform3 clearly bound to the chicken LDLRct (Fig. 44, A. lane 3b). 
No signals could be obtained with chicken Numb isoform1 or isoform2 as ligands 
(Fig. 44, A. lane 2; B. lanes 2 and 3). 
 
 
Cloning of the chicken Numb PRR insert 
 
As shown above the chicken Numb isoform3 containing the PRR insert binds to the 
cytoplasmic tails of the human and chicken LDLR, but isoforms 1 and 2 do not. 
The question arises whether the PRR inserted sequence is responsible for the 
observed interaction. To address this question, I cloned the 48-residue PRR insert to 
investigate the binding of this PRRi stretch to the human and chicken LDLR 
cytoplasmic tails. 
The chicken Numb isoform3 was used as a template for the RT-PCR, which was 
performed using the sequence-specific forward primer, 5’-
CAGAATTCCGTTAATGGCACTGCC-3’ (containing an EcoRI site, underlined), and 
the reverse primer 5’-GTCTCGAGGCCAGAGACCATGGC-3’ (containing an XhoI 
site, underlined). The sequence was verified by DNA sequencing. 
 
 
Bacterial expression of the recombinant chicken Numb PRR insert 
 
For the bacterially production of His6-tagged ggNumb PRRi the pET25b+-vector 
expression system was used. 
 
 
 
 
 
 
 
Figure 45. Schematic drawing of the recombinant chicken Numb-PRRi•HSV•6xHis 
fusion protein. 
The PRR insert (shown as a green box) was cloned into the pET25b+-expression vector, 
which carries an optional C-terminal HSV•Tag (blue box) and a 6xHis•Tag (red box) 
sequence. 
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The PRR insert cDNA was cloned between the EcoRI and XhoI sites of the 
pET25b+-vector, providing a C-terminal HSV-Tag and a 6xHis-Tag (Fig. 45). The 
construct was verified by DNA sequencing. The recombinant chicken Numb-
PRRi•HSV•6xHis fusion protein was bacterially expressed in BL21 cells. The 
induction of protein expression of the approximately 15 kDa ggNumb-PRRi-His fusion 
protein is shown in Fig. 46 A. to C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Bacterial expression of chicken Numb-PRRi•His fusion protein. 
The recombinant fusion protein was expressed in BL21 cells. Cell extracts, before 
(lane 1) and after (lane 2) 3 h of induction with 1mM IPTG, were subjected to SDS-
PAGE under reducing conditions and subsequently analyzed by Coomassie Blue stain 
(A.) and Western blotting using anti-HSV (B.) and anti-His (C.) antibodies. The bound 
primary antibodies were detected with with HRP-conjugated goat anti-mouse IgG 
(1:1500) (B. and C.) and enhanced chemiluminescence. The positions of migration 
(kDa) of marker proteins are indicated. 
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Interaction of the chicken Numb PRR insert with cytoplasmic domains of 
the chicken and human LDLR 
 
To test whether the PRRi stretch is involved in binding of chicken Numb isoform3 to 
the chicken and human LDLRct, the expressed PRR insert was used to perform 
ligand blots (Fig. 47). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. Interaction of the chicken Numb PRR insert with the chicken and human 
LDLR cytoplasmic tail. 
Nitrocellulose strips containing GST-His-ggLDLRct (A. lane 1: 0,5µg; lane 2: 1µg) or GST-
humanLDLRct-myc (B. lane 1: 0,5µg; lane 2: 1µg), separated by 12% SDS-PAGE under 
non-reducing conditions, were incubated with ggNumb-PRRi-HSV-His crude extract 
(150µg, A. and B. lane 2) . The strips were washed and incubated with anti-HSV antibody 
(A. and B. lane 2). GST-His-ggLDLRct and GST-humanLDLRct-myc were visualized by 
Western blotting by using anti-GST antibody (A. and B. lane 1). The primary antibodies 
were detected with HRP-conjugated goat anti-mouse IgG (1:1500) and enhanced 
chemiluminescence. The positions of migration (kDa) of marker proteins are indicated. 
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The bound ligand was depicted by immunoblotting with anti-HSV antibody (Fig. 47, 
A. and B. lane 2). The chicken Numb PRRi stretch bound to the chicken and human 
LDLR cytoplasmic tails, which were immunologically identified with anti-GST antibody 
(Fig. 47, A. and B. lane 1). 
These results produced clear evidence that the PRR insert is involved in, if not 
responsible for, the interaction of chicken Numb isoform3 with the chicken and 
human LDLR cytoplasmic tails. 
 
 
Binding of chicken LR8 and LR8B to chicken Numb 
 
LR8, the avian homologue of VLDLR, and LR8B, the chicken homologue of apoER2, 
are both engaged in receptor-mediated endocytosis. LR8 is responsible for the 
massive uptake of VLDL and VTG into the growing oocytes (Bujo, Hermann et al. 
1994; Schneider 1995). 
LR8B, expressed only in the brain, is participating in the clearance of α2-
macroglobulin-proteinase complexes (Novak, Hiesberger et al. 1996; Brandes, 
Novak et al. 1997; Stockinger, Hengstschlager-Ottnad et al. 1998). 
Due to their involvement in receptor-mediated endocytosis, I considered that Numb, 
as an adaptor protein, binds to the intracellular domains of chicken LR8 and/or LR8B. 
Therefore, ligand blots were performed with bacterially expressed and purified 
cytoplasmic tails of chicken LR8 (Fig. 48) and LR8B (Fig. 49) and chicken Numb 
isoforms. 
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Anti-ggNumb antiserum (Fig. 48, A. lanes 2a-3; B. lane 2), anti-HSV (Fig. 48, A. lane 
4), and anti-His (Fig. 48, B. lane 3) antibodies visualized binding of chicken Numb 
isoform1, isoform3, and the PRRi stretch. Furthermore the position of GST-ggLR8ct-
myc was identified with the anti-GST antibody (Fig. 48, A. and B. lane 1). The signal 
Figure 48. Binding of chicken Numb to the cytoplasmic domain of chicken LR8. 
Nitrocellulose strips containing GST-ggLR8ct-myc (A. lane 1: 2µg; lanes 2a-4: 3µg; B. lane 
1: 1,5µg; lanes 2-3: 3µg), separated by 12% SDS-PAGE under non-reducing conditions, 
were incubated with ggNumb-iso1-His crude extract (600µg, A. lanes 2a and 2b), ggNumb-
iso3-His crude extract (600µg, A. lane 3), ggNumb-PRRi-HSV-His crude (150µg, A. lane 4), 
and ggNumb-iso2-His crude extract (600µg, B. lanes 2-3). The strips were washed and 
incubated with anti-ggNumb antiserum (A. lanes 2a-3; B. lane 2), anti-HSV (A. lane 4), and 
anti-His (B. lane 3) antibodies. GST-ggLR8ct-myc was visualized by Western blotting by 
using anti-GST antibody (A. and B. lane 1). The primary antibodies were detected with 
HRP-conjugated goat anti-rabbit IgG (1:50000, A. lanes 2a-3; B. lane 2) or HRP-conjugated 
goat anti-mouse IgG (1:1500, A. lanes 1 and 4; B. lanes 1 and 3) and enhanced 
chemiluminescence. The difference between A. lane 2a and 2b is a different exposure time. 
The positions of migration (kDa) of marker proteins are indicated. 
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for the chicken Numb isoform1 binding was very weak (Fig. 48, A. lane 2b) and only 
could be demonstrated after a prolonged exposure time. Binding of isoform2 could 
not be detected (Fig. 48, B. lanes 2 and 3). The analogous experiment was 
performed with GST-ggLR8Bct-myc (Fig. 49). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49. Interaction of the cytoplasmic tail of chicken LR8B with chicken Numb. 
Nitrocellulose strips containing GST-ggLR8Bct-myc (A. lane 1: 2µg; lanes 2a-4: 3µg; B. 
lane 1: 1,5µg; lanes 2 and 3: 3µg), separated by 12% SDS-PAGE under non-reducing 
conditions, were incubated with ggNumb-iso1-His crude extract (600µg, A. lanes 2a and 
2b), ggNumb-iso3-His crude extract (600µg, A. lane 3), ggNumb-PRRi-HSV-His crude 
(150µg, A. lane 4), and ggNumb-iso2-His crude extract (600µg, B. lanes 2 and 3). The 
strips were washed and incubated with anti-ggNumb antiserum (A. lanes 2a-3; B. lane 2), 
anti-HSV (A. lane 4), and anti-His (B. lane 3) antibodies. GST-ggLR8ct-myc was visualized 
by Western blotting by using anti-GST antibody (A. and B. lane 1). The primary antibodies 
were detected with HRP-conjugated goat anti-rabbit IgG (1:50000, A. lanes 2a-3; B. lane 
2) or HRP-conjugated goat anti-mouse IgG (1:1500, A. lanes 1 and 4; B. lanes 1 and 3) 
and enhanced chemiluminescence. The difference between lane A. 2a and 2b is a longer 
exposure time. The positions of migration (kDa) of marker proteins are indicated. 
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Chicken LR8B cytoplasmic tail fusion protein was subjected to SDS-PAGE under 
non-reducing conditions, blotted onto nitrocellulose and incubated with the crude 
extracts of BL21 cells expressing ggNumb-iso1-His (Fig. 49, A. lanes 2a and 2b), 
ggNumb-iso2-His (Fig. 49, B. lanes 2 and 3), ggNumb-iso3-His (Fig. 49, A. lane 3), 
and ggNumb-PRRi-HSV-His (Fig. 49, A. lane 4). The GST-tagged LR8B cytoplasmic 
tail was visualized using anti-GST antibody (Fig. 49, A. and B. lane 1). 
As for the LR8 cytoplasmic tail (Fig. 48) chicken Numb isoform1 bound to the chicken 
LR8B cytoplasmic domain, but to a significantly smaller extent than ggNumb 
isoform3 and PRR insert did. Again, no binding of isoform2 could be obtained (Fig. 
49, B. lanes 2 and 3). 
The tails used in Fig. 47 to 49, namely the ggLDLRct, the human LDLRct, the 
ggLR8ct, and the ggLR8Bct were checked, if they cross-react with anti-HSV 
antibody, but no signal could be obtained (data not shown). 
 
 
Interaction of the chicken Amnionless cytoplasmic tail with adaptor 
proteins 
 
ARH (Autosomal Recessive Hypercholesterolemia) is another endocytic adaptor 
protein, which binds to the cytoplasmic tails of certain LDLR family members (Mishra, 
Watkins et al. 2002; Traub 2003). Endocytic adaptors are necessary to connect 
transmembrane proteins with the clathrin-mediated endocytosis machinery (Mousavi, 
Malerod et al. 2004). For instance, ARH has been shown to be important for LRP2-
mediated endocytosis (Nagai, Meerloo et al. 2003). Amnionless, like LRP2, is a co-
receptor for Cubilin and contains internalization sequences for receptor-mediated 
endocytosis. 
It was shown in preliminary experiments that the cytoplasmic tail of chicken 
Amnionless binds to chicken ARH (Christian 2006). Thus, first I confirmed this finding 
by performing a co-immunoprecipitation (Co-IP) and a ligand blot as described in 
Materials and Methods. The antiserum against ARH used (anti-ARH), was described 
in (Grünstäudl 2005), and originally designated antiserum #65. The anti-ARH 
antiserum was generated against a peptide corresponding to amino acid 89-117 of 
human ARH, and it was shown that this antibody cross-reacts with the chicken ARH. 
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His-tagged chicken Amnionless cytoplasmic tail (ggAmnionless ct-His) was incubated 
with GST-ggARH and the mixture was precipitated by using anti-ARH antiserum. The 
precipitate was analyzed for the presence of co-precipitated ggAmnionless ct-His by 
Western blotting using the anti-His antibody as the primary antibody (Fig. 50). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It could be shown that the cytoplasmic tail of chicken Amnionless binds to the 
chicken ARH (Fig. 50, lane 1). When the chicken Amnionless ct was incubated with 
Protein A Sepharose alone (Fig. 50, lane 2) or only with the anti-ARH antibody and 
Protein A Sepharose (not shown), no binding was detectable. 
The same result could be observed by ligand blotting (Fig. 51). 
 
 
 
 
 
 
 
Figure 50. Chicken Amnionless intacellular domain binds to the chicken adaptor 
protein ARH. 
1µg of ggAmnionless ct-His protein was preincubated with (lane 1) or without (lane 2) 
7,5µg of purified GST-ggARH and then mixed with anti-ARH antiserum. Subsequently, 
Protein A Sepharose was added, and the immunoprecipitated material was separated by 
15% SDS-PAGE under reducing conditions. The nitrocellulose membrane was then 
incubated with anti-His antibody. The primary antibody was detected with HRP-conjugated 
goat anti-mouse IgG (1:1500) and enhanced chemiluminescence. The positions of 
migration (kDa) of marker proteins are indicated. 
Results 
 - 82 -
Figure 51. Recombinant His-tagged ggAmnionless cytoplasmic tail binds to the 
GST-tagged ARH. 
Nitrocellulose strips containing purified GST-ggARH protein (lanes 1 and 2: 0,5µg; lane 3: 
2µg) separated by 10% SDS-PAGE under non-reducing conditions, were incubated with 
ggAmnionless ct-His (20µg, lane 3). The strip shown in lane 3 was washed and incubated 
with anti-His antibody. GST-ggARH was visualized by Western blotting by using either 
anti-GST antibody (lane 1) or anti-ARH antiserum (lane 2). The primary antibodies were 
detected with HRP-conjugated goat anti-rabbit IgG (1:50000, lane 2) or HRP-conjugated 
goat anti-mouse IgG (1:1500, lanes 1 and 3) and enhanced chemiluminescence. In lane 
3, a longer exposure time was used. 
The positions of migration (kDa) of marker proteins are indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The bound ligand was visualized with anti-His antibody (Fig. 51, lane 3). 
GgAmnionless ct-His clearly bound to GST-ggARH, which migrate as an 
approximately 65 kDa protein. The position of migration of GST-ggARH was 
identified with anti-GST (Fig. 51, lane 1) and anti-ARH (Fig. 51, lane 2) antibodies, 
respectively. 
 
ARH binds to the FxNPxY motif in the cytoplasmic tails of the LDLR receptor family 
members via the phosphotyrosine-binding (PTB) domain (Mishra, Watkins et al. 
2002; Yan, Kuti et al. 2002). Numb also possesses such a PTB domain, which is 
evolutionarily and most closely related to that of ARH (Mishra, Watkins et al. 2002). 
Numb is known to associate with clathrin-coated pits (CCPs), vesicles, and 
endosomes, and therefore was suggested to function as an endocytic adaptor protein 
(Santolini, Puri et al. 2000). 
Since chicken ARH is able to bind to the chicken Amnionless cytoplasmic tail, the 
question arose whether the chicken Numb isoforms are also able to bind to it. 
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Therefore, a ligand blot with the chicken Amnionless cytoplasmic tail and the different 
chicken Numb isoforms was performed (Fig. 52). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results obtained with the various chicken Numb isoforms are depicted in Fig. 52. 
As I wanted to determine the ability of Numb to bind to the chicken Amnionless 
cytoplasmic tail, the proteins were electrophoretically separated under non-reducing 
conditions (Fig. 52, lanes 1-5). The proteins were blotted onto nitrocellulose 
membrane and incubated with crude extracts of bacteria expressing ggNumb 
isoform1 (Fig. 52, lane 2), ggNumb isoform2 (Fig. 52, lane 5), and ggNumb isoform3 
(Fig. 52, lane 3). The binding of the Numb isoforms was tested by using anti-ggNumb 
antiserum (Fig. 52, lanes 2-5). The position of ggAmnionless ct-His was visualized by 
Western blotting with anti-His antibody (Fig. 52, lane 1). 
Figure 52. Chicken Numb isoforms do not bind the chicken Amnionless cytoplasmic 
tail. 
Nitrocellulose strips containing ggAmnionless ct-His (1,5µg/lane), separated by 15% SDS-
PAGE under non-reducing conditions, were incubated with 300µg crude extract of ggNumb 
isoform1 (lane 2), ggNumb isoform2 (lane 5), and ggNumb isoform3 (lane 3). The strips 
were washed and incubated with anti-ggNumb antiserum (lanes 2, 3, and 5). 
GgAmnionless ct was visualized by Western blotting with anti-His antibody (lane 1). In lane 
4 the blot was incubated with anti-ggNumb to test for cross-reactivity with the 
ggAmnionless ct. The primary antibodies were detected with HRP-conjugated goat anti-
mouse IgG (lane 1; 1:1500) or HRP-conjugated goat anti-rabbit IgG (lanes 2-5; 1:50000) 
and enhanced chemiluminescence. The postions of migration (kDa) of marker proteins are 
indicated. 
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Interestingly, although chicken Amnionless (Ensembl database, 
ENSGALT00000018581), contains the presumptive internalization signals FDNPMF 
and YINPLY (Fig. 53), it interacts with chicken ARH, but does not appear to bind to 
chicken Numb. 
 
 
 
 
 
 
 
 
 
 
 
All shown alignments in this thesis were made with the alignment program from 
www.ebi.ac.uk, except for Fig. 53, the alignment program from www.ch.embnet.org 
was used. 
 
 
 
Figure 53. Alignment of cytoplasmic tails of receptors studied. 
The human LDLR, the chicken LDLR, the chicken LR8, and the chicken LR8B 
cytoplasmic tails contain one internalization signal (enboxed in green). While the chicken 
Amnionless cytoplasmic tail contains two internalization motifs. 
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Discussion 
 
 
Characterization of the chicken LDLR ligand binding 
domain 
 
The first part of this thesis deals with the elucidation of binding properties of the avian 
LDLR’s extracellular domain based on our knowledge about the human LDLR. This 
receptor is the first characterized and most prominent member of the LDLR gene 
family (Brown and Goldstein 1974; Goldstein and Brown 1974). The investigation of 
the human genetic disease, familial hypercholesterolemia (FH), led to the discovery 
of the LDLR and to the identification of the LDLR as the key component in the 
feedback-regulated maintenance of cholesterol homeostasis in the body (Goldstein, 
Brown et al. 1985). The LDLR binds and internalizes cholesterol-rich lipoproteins 
containing apolipoprotein B100 (apoB100) or E (apoE), and thereby plays a role in 
both supplying all cells with cholesterol and reducing the risk of atherosclerosis. The 
high degree of specificity of the LDLR for apoB100 and apoE is recognized to reside 
in its domain structure. The LDLR is composed of structurally and functionally 
defined modules. These modules are: i) the ligand binding domain consisting of 
seven ligand binding type A (LA) repeats, ii) the so-called EGF precursor homology 
domain, iii) an O-linked sugar domain, iv) a membrane anchoring domain, and v) a 
cytoplasmic tail. 
While much is known about the features required for recognition of ligands and for 
receptor internalization, respectively, there are still some open issues. For this study, 
the ligand binding domain, which mediates the interaction between the receptor and 
lipoproteins containing apoB100 and apoE (Esser, Limbird et al. 1988), and the 
cytoplasmic tail containing an internalization signal involved in connecting the LDLR 
to the clathrin-mediated endocytosis machinery, are of great interest. 
In the chicken, which is the model organism in our laboratory, the LDLR has been 
identified a few years ago (Hummel, Lynn et al. 2003). The structure of the avian 
LDLR is largely congruent with that of mammalian LDLRs, in that it contains all of the 
common structural elements of the LDLR family members. 
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One notable difference in the chicken LDLR is an Alanine/Glutamate-rich stretch 
(also termed linker) between LA binding repeats 4 and 5, which is not present in the 
human LDLR (see Fig. 22). 
It has been shown that rabbit β–VLDL, an apoE-rich class of lipoprotein particles, 
binds to the human LDLR via apoE. The major chicken oocyte lipoprotein receptor, 
LR8, is highly homologous to the mammalian VLDLR, which is known to bind apoE 
(Bujo, Hermann et al. 1994). LR8 is responsible for the uptake of VLDL and 
vitellogenin (VTG) into the growing oocyte. Chicken LR8 can interact with human 
apoE (Fig. 24), but the chicken LDLR does not (Hayashi, Nimpf et al. 1989; Steyrer, 
Barber et al. 1990). The observation that chicken LR8 binds human apoE is 
remarkable considering that birds do not synthesize apoE (Steyrer, Barber et al. 
1990). In this context, since LR8 transports VTG, this ligand has been suggested to 
represent a functional analog of apoE (Steyrer, Barber et al. 1990). 
It is known that the negatively charged cluster Ser-Asp-Glu (SDE) in the fifth repeat 
of the LDLR ligand binding domain plays a crucial role in the interaction of β–
VLDL/apoE and LDL with the LDLR (Esser, Limbird et al. 1988). Therefore, the fifth 
repeat is probably the most important LA repeat for the binding of LDL and β–VLDL. 
However, as described below, other features also appear to be involved. 
The approach to shed further light on receptor/ligand interactions was to introduce 
mutations into the chicken ligand binding domain to render the chicken LDLR’s 
extracellular domain more similar to that of the human receptor, and to possibly 
enable the binding of human apoE to the altered chicken LDLR. In order to search for 
sequence motifs necessary for these interactions, SDEE in repeat 1 was replaced by 
SDES (see Fig. 23, LA7m), because the apoE-binding human LDLR and chicken 
LR8 contain an SDES motif at this position, suggesting that this sequence maybe 
required for the interaction. 
The LA7m5 mutant (Fig. 23), in which SDED in repeat 5 was replaced by SDEE, was 
generated because as mentioned above, the SDE cluster in the fifth repeat in the 
human LDLR likely is crucial. In LA7∆ (Fig. 23) the insert into the linker between 
repeats 4 and 5 was deleted, and only the number of amino acids present between 
the two repeats in the human LDLR remained. The assumption was that the long 
linker may change the conformation of the LA repeats, and/or their positioning within 
the ligand binding domain, so that human apoE is unable to bind. In the LA7 double 
mutant, LA7dbl (Fig. 23), the mutations LA7m and LA7m5 were introduced together 
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in order to cover the possibility that a combination of these mutations is necessary for 
mediating the interaction of human apoE with the chicken LDLR’s ligand binding 
domain. 
The mutations leading to these substitutions and the deletion, respectively (Fig. 23), 
were achieved using site-directed mutagenesis. The wt and the four different mutated 
LA7 domains were expressed and refolded. The refolding in the presence of RAP-
Sepharose was necessary to gain the full binding activity of the ligand binding 
domains, as was also shown in a recent publication using the β–propeller domains of 
the LDLR relative LRP6 (Liu, Pearson et al. 2009). The refolding, which is essentially 
dependent on disulfide bridges, is abolished when reducing conditions are used. This 
is also reflected by the fact that the proteins migrate slower in SDS gels under 
reducing conditions (Fig. 26 and 27). The binding ability of the folded wt and mutant 
LA7 domains was analyzed by co-immunoprecipitation with His-RAP-myc (Fig. 28), 
which showed that the mutated LA7s are active and are able to form receptor-ligand 
complexes. 
Subsequently, the different LA7 domains were tested for their ability to bind the 3 
different human apoE isoforms by performing ligand blotting, but signals could 
unfortunately not be obtained (data not shown). Maybe this failure to interact is due 
to the recovery of correctly folded protein being too low for demonstrating apoE-
binding, albeit it is sufficient for showing interaction with RAP. Alternatively, the 
refolding of the bacterially expressed proteins in the presence of RAP-Sepharose 
may not be sufficient, and production of the different LA domains by the intrinsic 
folding machinery of eukaryotic cells for secretion would result in a better yield. 
Another reason could be that the analysis of the interaction via ligand blotting, 
although successfully applied in many studies from our laboratory [e.g. (Dichlberger, 
Cogburn et al. 2007)], is not the most sensitive method. In a recent publication, 
fluorescence resonance energy transfer (FRET) was used for analysis of such 
interactions (Yamamoto and Ryan 2009); however, such experiments were beyond 
the frame of this thesis. 
The chicken LDLR has only been detected in somatic cells, does not bind β-
VLDL/apoE, and is not able to cross-react with an antibody against bovine LDLR; in 
contrast, LR8 is present in oocytes, does bind β-VLDL, and cross-reacts with an 
antibody against the bovine LDLR (Hayashi, Ando et al. 1989; Hayashi, Nimpf et al. 
1989). Since VTG may represent the equivalent of apoE in oviparous species, and 
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the chicken LDLR is not directly involved in oocyte growth, it appears logical that 
apoE is not a ligand for the chicken LDLR. Based on these assumptions, another 
approach would be to compare the sequences of ggLR8 and the ggLDLR and 
introduce mutations into the ggLDLR to render it more similar to ggLR8, as already 
achieved in the LA7m mutant. 
 
Protein interaction properties of the intracellular domains 
of LDLR family members 
 
The cytoplasmic tails of the LDLR family members interact with classical adaptor 
proteins such as AP2, and with alternative adaptors including ARH, Dab2, and Numb 
(Traub 2003). The adaptor proteins are required to select receptors for clathrin-
mediated internalization (Mousavi, Malerod et al. 2004). It is known that ARH binds to 
the NPxY motif in the cytoplasmic tails of the LDLR family members as well as to 
components of clathrin-coated pits (He, Gupta et al. 2002; Mishra, Watkins et al. 
2002). It has been shown that human and chicken ARH bind to the cytoplasmic tails 
of LDLRs from chicken as well as man (Grünstäudel 2005). It was of interest to 
investigate whether Numb, which is closely related to ARH, is also able to interact 
with the LDLR’s cytoplasmic tail (Mishra, Watkins et al. 2002). Numb was originally 
identified as a cell fate determinant in the nervous sytem of Drosophila (Uemura, 
Shepherd et al. 1989; Rhyu, Jan et al. 1994). Due to the fact that Numb interacts with 
AP2 and associates with clathrin-coated pits, vesicles, and endosomes, it was 
suggested that it functions as an endocytic adaptor (Santolini, Puri et al. 2000; 
Tokumitsu, Hatano et al. 2006). The group of Wakamatsu also identified a chicken 
Numb protein (Fig. 31) (Wakamatsu, Maynard et al. 1999). 
Chicken Numb displays 83% sequence identity with human and murine Numb (Fig. 
30) and appears to be evolutionarily well conserved. In mammals, four different 
isoforms of Numb are known. By BLAST search, different chicken Numb isoforms 
have been revealed that differ in the presence or absence of inserts in the 
phosphotyrosine-binding domain (PTB) and in the proline-rich region (PRR) (Fig. 33). 
It is interesting that the potential chicken Numb phosphotyrosine-binding domain 
insert (PTBi) contains 11 amino acids (aa), which are 100% conserved in mammals, 
whereas the proline-rich region insert (PRRi) is 48 aa long and shares about 56% 
sequence identity with the mammalian insert, which lies adjacent to the PRR domain 
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(Dho, French et al. 1999). The PRR insert is less conserved, which is compatible with 
the PRR inserted sequence in the chicken protein having specific functions not 
required in mammalian systems. The chicken Numb isoforms 1 to 3 were cloned, 
expressed, and used for interaction studies. The chicken Numb isoform2 contains an 
additional in-frame insert immediately before the canonical PTB insert (Fig. 37), 
whose sequence was also found in the chicken Ensembl database. This novel insert 
preceding the PTB insert is not present in the Numb isoform2 of any organism and 
thus is a new finding in the chicken. The difference may result from alternative 
splicing only in the avian species, and may allow to increase or decrease the binding 
ability of Numb isoform2 to cytoplasmic tails of the chicken LDLR family members. 
I could not clearly obtain cDNA for chicken Numb isoform4. One reason could be that 
the transcripts for isoforms 3 and 4 are nearly the same size, with a difference of only 
33 bp, and so it was not feasible to separate them. Other reasons could be that 
chicken Numb isoform4 is not at all expressed, or simply that the gene sequence 
reported in the Ensembl database is wrong. 
Mammalian Numb, containing an insert in the PTB domain or not, is able to efficiently 
bind to Ligand of Numb-protein X (LNX) and both domains show binding to acidic 
phospholipids (Dho, Jacob et al. 1998; Dho, French et al. 1999). In contrast, the PRR 
domain of the human Numb containing the insert promotes neuronal proliferation 
during mammalian neurogenesis, whereas the PRR domain without the insert 
enhances neuronal differentiation. Thus, the Numb-PRRs with and without the insert, 
respectively, can fulfill different functions (Verdi, Bashirullah et al. 1999). Thus, if 
chicken Numb is able to bind LDLR’s cytoplasmic tails, the question arises whether 
the inserts make a difference. 
The finding that chicken Numb isoform3 binds to the human and to the chicken 
LDLRct, but Numb isoforms 1 and 2 do not, was surprising. Possibly, this difference 
is caused by the fact that the insert in the mammalian Numb PTB domain did not 
change the binding ability of the PTB domain to the NPxY sequence motif (Dho, 
Jacob et al. 1998). Maybe the newly identified additional insert in chicken Numb 
isoform2 alters the binding capacity or leads to an conformational change, or both, 
which leads to an inhibition of the interaction. 
The astonishing fact that only chicken Numb isoform3 interacts with the cytoplasmic 
tails of the human and chicken LDLR raises the question whether the PRR insert is 
actually responsible for this interaction. Indeed, by testing whether the insert alone is 
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able to bind to the human and chicken LDLR’s cytoplasmic tails or not, I showed that 
the PRRi stretch binds to both tails (Fig. 47). This result produced clear evidence that 
the PRR inserted sequence plays a role in the interaction of chicken Numb isoform3 
with the chicken and human LDLR’s cytoplasmic tails, which is a new finding, 
because thus far only the PTB domain was shown to bind to the NPxY motif in the 
cytoplasmic tail (Yan, Kuti et al. 2002). 
Based on the fact that Numb is an endocytic adaptor protein (Santolini, Puri et al. 
2000) and is able to bind cytoplasmic tails of the human and chicken LDLR (see 
above), it was of interest to test whether Numb may bind to other cytoplasmic tails of 
receptors involved in receptor-mediated endocytosis. Candidate receptors in the 
chicken include LR8 and LR8B. LR8 is highly homologous to the mammalian VLDLR 
and has a well established function in the avian species (Bujo, Hermann et al. 1994; 
Schneider 1995). LR8B, the chicken homologue of the mammalian apoE receptor 
type 2 (apoER2), is apparently only expressed in the brain (Novak, Hiesberger et al. 
1996; Brandes, Novak et al. 1997), where it takes part in the clearance of α2-
macroglobulin-proteinase complexes (Stockinger, Hengstschlager-Ottnad et al. 
1998). 
As observed in the case of the human and chicken LDLRs, an interaction of the 
cytoplasmic tails of LR8 and LR8B with chicken Numb isoform2 could not be 
detected; however, the PRRi stretch alone is able to bind (Fig. 48 and 49), which is 
indistinguishable from the situation with the cytoplasmic tails of the chicken and 
human LDLR (see above). Reasons for the apparently weaker interaction of the 
intracellular domains of the LR8 and LR8B with chicken Numb isoform1 than with 
isoform3 (Fig. 48 and 49) or with the PRR insert could be that isoform1 is a poorer 
binding partner for LR8 and LR8B than isoform3, and that the PRRi stretch is 
necessary to gain the full binding activity of chicken Numb to intracellular domains. 
The insert in the PTB domain in isoform2 may abolish the interaction between Numb 
and the cytoplasmic tails. Thus, the PTB insert may disturb the binding activity of 
isoform2 compared to isoform1. In a recent publication it was shown that Numb 
proteins that differ in the PTB domains have opposite effects on the transport and 
processing of amyloid precursor protein (APP) (Kyriazis, Wei et al. 2008). It may be 
that in the chicken, the insert in the PTB domain abolishes the binding ability of 
Numb, while the insert in the PRR domain promotes this interaction. The PRR 
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inserted sequence may employ other motifs for binding than the PTB domain is 
known to use (He, Gupta et al. 2002). 
 
I also investigated the properties of a receptor whose extracellular domain is very 
different from those of the LDLR family and thus appears unrelated to the LDLR 
family, but due to its containing two internalization motifs in its cytoplasmic domain 
was of obvious interest. This membrane protein is Amnionless, initially identified as a 
yolk sac protein for formation of the amnion and primitive streak in the mouse 
(Kalantry, Manning et al. 2001). Amnionless is a type I transmembrane protein and 
contains two receptor internalization NPxY motifs reminiscent of those in LDLR family 
members (Kalantry, Manning et al. 2001). Recently, it was shown that mutations in 
the amnionless gene can cause the autosomal recessive disorder, Imerslund-
Gräsbeck syndrome (IGS) (Aminoff, Carter et al. 1999; Tanner, Aminoff et al. 2003). 
IGS is characterized by selective malabsorption of cobalamin (vitamin B12) in the 
intestine, leading to megaloblastic anemia and degeneration of the nervous system 
(Grasbeck, Gordin et al. 1960; Imerslund 1960). The malabsorption is caused by the 
inability of the Cubilin/Amnionless (cubam) complex to bind to intrinsic factor, a 
glycoprotein tightly binding cobalamin and ensuring its absorption from the intestine 
(Fyfe, Madsen et al. 2004). The interaction of Amnionless and Cubilin is the key to 
the co-internalization of ligands bound to Cubilin. Surprisingly, Amnionless was 
previously demonstrated also in the chicken (Christian 2006) as a 51kDa protein with 
a high degree of sequence similarity with the murine and canine homologues. It is 
intriguing to hypothesize that the two internalization sequences in Amnionless, 
FDNPMF and YINPLY, may be important for a direct role in receptor-mediated 
endocytosis, especially for ligand transport into the chicken embryo’s yolk sac. 
Thus, the binding of chicken ARH to the chicken Amnionless intracellular domain 
demonstrated by co-immunoprecipitation (Fig. 50) and ligand blotting (Fig. 51) may 
indicate an involvement in mediating endocytosis of Amnionless. 
Furthermore, since Numb is an adaptor protein, and its PTB domain is closely related 
to that in ARH, the question arose whether chicken Amnionless and chicken Numb 
are able to interact with each other as well. However, ligand blot analysis revealed 
that chicken Amnionless likely does not bind chicken Numb (Fig. 52), despite the fact 
that Amnionless contains internalization motifs and interacts with ARH. One 
explanation for the lack of interaction between the cytoplasmic tail of Amnionless with 
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chicken Numb could be that the anti-ggNumb antiserum does not have sufficient 
avidity to detect interaction. Alternatively, the binding may not take place because 
chicken Numb fails to interact with the internalization motifs, which are similar to, but 
nevertheless different from those in the tails of the LDLR family members, I 
investigated. 
The failure to bind may also indicate that the different physiology of avian species 
does not require specific adaptor interaction for internalization, or that uptake 
pathways involving Amnionless, a protein required for the formation of the amnion, 
are dispensable in oviparous species. 
 
In conclusion, mutating the LDLR’s extracellular domain produced different LA 
domains that were active and were able to form certain receptor-ligand complexes. 
However, the binding of human apoE may require highly specific conformations that 
were not met by the mutant forms, and the nature of which remains to be elucidated. 
Four different chicken Numb isoforms were identified at the genome level, and 
isoform3 was determined as binding partner of the cytoplasmic tails of the human 
and the avian LDLR, of chicken LR8, and of LR8B, likely via the extra-long insert in 
the PRR domain of this isoform. Additionally, the insert-lacking chicken Numb 
isoform1 binds to the intracellular domains of LR8 and LR8B, possibly enhancing 
endocytosis of these receptors.  
Finally, the results of studies on the interaction between the cytoplasmic tail of 
chicken Amnionless and chicken Numb isoforms indicate that such interaction may 
not be as crucial to the physiological roles of this receptor in avian species as in 
mammals. 
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